id	sid	tid	token	lemma	pos
ajrhss-623	1	1	american	american	PROPN
ajrhss-623	1	2	journal	journal	PROPN
ajrhss-623	1	3	of	of	ADP
ajrhss-623	1	4	research	research	NOUN
ajrhss-623	1	5	in	in	ADP
ajrhss-623	1	6	humanities	humanity	NOUN
ajrhss-623	1	7	and	and	CCONJ
ajrhss-623	1	8	social	social	ADJ
ajrhss-623	1	9	sciences	science	NOUN
ajrhss-623	1	10	issn	issn	PROPN
ajrhss-623	1	11	(	(	PUNCT
ajrhss-623	1	12	e	e	NOUN
ajrhss-623	1	13	):	):	PUNCT
ajrhss-623	1	14	2832	2832	NUM
ajrhss-623	1	15	-	-	SYM
ajrhss-623	1	16	8019	8019	NUM
ajrhss-623	1	17	volume	volume	NOUN
ajrhss-623	1	18	11	11	NUM
ajrhss-623	1	19	,	,	PUNCT
ajrhss-623	1	20	|	|	ADV
ajrhss-623	1	21	april	april	PROPN
ajrhss-623	1	22	,	,	PUNCT
ajrhss-623	1	23	2023	2023	NUM
ajrhss-623	1	24	p	p	NOUN
ajrhss-623	1	25	a	a	DET
ajrhss-623	1	26	g	g	NOUN
ajrhss-623	1	27	e	e	NOUN
ajrhss-623	1	28	|	|	ADV
ajrhss-623	1	29	66	66	NUM
ajrhss-623	1	30	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-623	1	31	diagnostics	diagnostic	NOUN
ajrhss-623	1	32	and	and	CCONJ
ajrhss-623	1	33	management	management	NOUN
ajrhss-623	1	34	of	of	ADP
ajrhss-623	1	35	non	non	ADJ
ajrhss-623	1	36	-	-	ADJ
ajrhss-623	1	37	gravidary	gravidary	ADJ
ajrhss-623	1	38	urgent	urgent	ADJ
ajrhss-623	1	39	uterine	uterine	ADJ
ajrhss-623	1	40	bleeding	bleeding	NOUN
ajrhss-623	1	41	according	accord	VERB
ajrhss-623	1	42	to	to	ADP
ajrhss-623	1	43	international	international	ADJ
ajrhss-623	1	44	recommendations	recommendation	NOUN
ajrhss-623	1	45	parpiyeva	parpiyeva	VERB
ajrhss-623	1	46	sh.o	sh.o	PROPN
ajrhss-623	1	47	.	.	PUNCT
ajrhss-623	2	1	,	,	PUNCT
ajrhss-623	2	2	3rd	3rd	ADJ
ajrhss-623	2	3	year	year	NOUN
ajrhss-623	2	4	master	master	NOUN
ajrhss-623	2	5	’s	’s	PART
ajrhss-623	2	6	student	student	NOUN
ajrhss-623	2	7	of	of	ADP
ajrhss-623	2	8	the	the	DET
ajrhss-623	2	9	2nd	2nd	ADJ
ajrhss-623	2	10	department	department	NOUN
ajrhss-623	2	11	of	of	ADP
ajrhss-623	2	12	obstetrics	obstetric	NOUN
ajrhss-623	2	13	and	and	CCONJ
ajrhss-623	2	14	gynecology	gynecology	NOUN
ajrhss-623	2	15	,	,	PUNCT
ajrhss-623	2	16	andijan	andijan	NOUN
ajrhss-623	2	17	state	state	PROPN
ajrhss-623	2	18	medical	medical	PROPN
ajrhss-623	2	19	institute	institute	PROPN
ajrhss-623	2	20	associate	associate	PROPN
ajrhss-623	2	21	professor	professor	NOUN
ajrhss-623	2	22	yakubova	yakubova	PROPN
ajrhss-623	2	23	o.	o.	PROPN
ajrhss-623	2	24	a.	a.	PROPN
ajrhss-623	2	25	scientific	scientific	PROPN
ajrhss-623	2	26	supervisor	supervisor	NOUN
ajrhss-623	2	27	:	:	PUNCT
ajrhss-623	2	28	head	head	NOUN
ajrhss-623	2	29	.	.	PUNCT
ajrhss-623	3	1	head	head	NOUN
ajrhss-623	3	2	of	of	ADP
ajrhss-623	3	3	the	the	DET
ajrhss-623	3	4	department	department	NOUN
ajrhss-623	3	5	of	of	ADP
ajrhss-623	3	6	obstetrics	obstetric	NOUN
ajrhss-623	3	7	-	-	PUNCT
ajrhss-623	3	8	gynecology	gynecology	NOUN
ajrhss-623	3	9	and	and	CCONJ
ajrhss-623	3	10	oncology	oncology	NOUN
ajrhss-623	3	11	of	of	ADP
ajrhss-623	3	12	the	the	DET
ajrhss-623	3	13	faculty	faculty	NOUN
ajrhss-623	3	14	of	of	ADP
ajrhss-623	3	15	improvement	improvement	NOUN
ajrhss-623	3	16	and	and	CCONJ
ajrhss-623	3	17	retraining	retraining	NOUN
ajrhss-623	3	18	of	of	ADP
ajrhss-623	3	19	doctors	doctor	NOUN
ajrhss-623	3	20	of	of	ADP
ajrhss-623	3	21	the	the	DET
ajrhss-623	3	22	asmi	asmi	NOUN
ajrhss-623	3	23	,	,	PUNCT
ajrhss-623	3	24	doctor	doctor	NOUN
ajrhss-623	3	25	of	of	ADP
ajrhss-623	3	26	medical	medical	ADJ
ajrhss-623	3	27	sciences	science	NOUN
ajrhss-623	3	28	,	,	PUNCT
ajrhss-623	3	29	a	a	DET
ajrhss-623	3	30	b	b	PROPN
ajrhss-623	3	31	s	s	ADP
ajrhss-623	3	32	t	t	PROPN
ajrhss-623	3	33	r	r	NOUN
ajrhss-623	3	34	a	a	DET
ajrhss-623	3	35	c	c	NOUN
ajrhss-623	3	36	t	t	NOUN
ajrhss-623	3	37	k	k	X
ajrhss-623	3	38	e	e	PROPN
ajrhss-623	3	39	y	y	PROPN
ajrhss-623	3	40	w	w	NOUN
ajrhss-623	3	41	o	o	NOUN
ajrhss-623	3	42	r	r	NOUN
ajrhss-623	3	43	d	d	X
ajrhss-623	3	44	s	s	VERB
ajrhss-623	3	45	abnormal	abnormal	ADJ
ajrhss-623	3	46	uterine	uterine	ADJ
ajrhss-623	3	47	bleeding	bleeding	NOUN
ajrhss-623	3	48	(	(	PUNCT
ajrhss-623	3	49	amb	amb	PROPN
ajrhss-623	3	50	)	)	PUNCT
ajrhss-623	3	51	is	be	AUX
ajrhss-623	3	52	a	a	DET
ajrhss-623	3	53	general	general	ADJ
ajrhss-623	3	54	term	term	NOUN
ajrhss-623	3	55	used	use	VERB
ajrhss-623	3	56	to	to	PART
ajrhss-623	3	57	describe	describe	VERB
ajrhss-623	3	58	uterine	uterine	ADJ
ajrhss-623	3	59	bleeding	bleeding	NOUN
ajrhss-623	3	60	that	that	PRON
ajrhss-623	3	61	exceeds	exceed	VERB
ajrhss-623	3	62	the	the	DET
ajrhss-623	3	63	volume	volume	NOUN
ajrhss-623	3	64	and	and	CCONJ
ajrhss-623	3	65	duration	duration	NOUN
ajrhss-623	3	66	of	of	ADP
ajrhss-623	3	67	normal	normal	ADJ
ajrhss-623	3	68	menstruation	menstruation	NOUN
ajrhss-623	3	69	in	in	ADP
ajrhss-623	3	70	women	woman	NOUN
ajrhss-623	3	71	of	of	ADP
ajrhss-623	3	72	reproductive	reproductive	ADJ
ajrhss-623	3	73	age	age	NOUN
ajrhss-623	3	74	(	(	PUNCT
ajrhss-623	3	75	fraiser	fraiser	VERB
ajrhss-623	3	76	i.s	i.s	PROPN
ajrhss-623	3	77	.	.	PROPN
ajrhss-623	3	78	,	,	PUNCT
ajrhss-623	3	79	langham	langham	PROPN
ajrhss-623	3	80	s.	s.	PROPN
ajrhss-623	3	81	,	,	PUNCT
ajrhss-623	3	82	2009	2009	NUM
ajrhss-623	3	83	)	)	PUNCT
ajrhss-623	3	84	.	.	PUNCT
ajrhss-623	4	1	abnormal	abnormal	ADJ
ajrhss-623	4	2	uterine	uterine	ADJ
ajrhss-623	4	3	bleeding	bleeding	NOUN
ajrhss-623	4	4	occurs	occur	VERB
ajrhss-623	4	5	in	in	ADP
ajrhss-623	4	6	14	14	NUM
ajrhss-623	4	7	-	-	SYM
ajrhss-623	4	8	25	25	NUM
ajrhss-623	4	9	%	%	NOUN
ajrhss-623	4	10	of	of	ADP
ajrhss-623	4	11	women	woman	NOUN
ajrhss-623	4	12	of	of	ADP
ajrhss-623	4	13	reproductive	reproductive	ADJ
ajrhss-623	4	14	age	age	NOUN
ajrhss-623	4	15	(	(	PUNCT
ajrhss-623	4	16	adamyan	adamyan	PROPN
ajrhss-623	4	17	l.v	l.v	PROPN
ajrhss-623	4	18	.	.	PROPN
ajrhss-623	4	19	,	,	PUNCT
ajrhss-623	4	20	sibirskaya	sibirskaya	PROPN
ajrhss-623	5	1	e.v	e.v	PROPN
ajrhss-623	5	2	.	.	PROPN
ajrhss-623	5	3	,	,	PUNCT
ajrhss-623	5	4	koltunova	koltunova	X
ajrhss-623	5	5	i.e.	i.e.	X
ajrhss-623	5	6	,	,	PUNCT
ajrhss-623	5	7	2016	2016	NUM
ajrhss-623	5	8	)	)	PUNCT
ajrhss-623	6	1	and	and	CCONJ
ajrhss-623	6	2	can	can	AUX
ajrhss-623	6	3	have	have	VERB
ajrhss-623	6	4	a	a	DET
ajrhss-623	6	5	significant	significant	ADJ
ajrhss-623	6	6	impact	impact	NOUN
ajrhss-623	6	7	on	on	ADP
ajrhss-623	6	8	their	their	PRON
ajrhss-623	6	9	physical	physical	ADJ
ajrhss-623	6	10	,	,	PUNCT
ajrhss-623	6	11	social	social	ADJ
ajrhss-623	6	12	,	,	PUNCT
ajrhss-623	6	13	emotional	emotional	ADJ
ajrhss-623	6	14	and	and	CCONJ
ajrhss-623	6	15	material	material	ADJ
ajrhss-623	6	16	quality	quality	NOUN
ajrhss-623	6	17	of	of	ADP
ajrhss-623	6	18	life	life	NOUN
ajrhss-623	6	19	.	.	PUNCT
ajrhss-623	7	1	abnormal	abnormal	ADJ
ajrhss-623	7	2	uterine	uterine	ADJ
ajrhss-623	7	3	bleeding	bleeding	NOUN
ajrhss-623	7	4	in	in	ADP
ajrhss-623	7	5	reproductive	reproductive	ADJ
ajrhss-623	7	6	age	age	NOUN
ajrhss-623	7	7	is	be	AUX
ajrhss-623	7	8	associated	associate	VERB
ajrhss-623	7	9	with	with	ADP
ajrhss-623	7	10	various	various	ADJ
ajrhss-623	7	11	types	type	NOUN
ajrhss-623	7	12	of	of	ADP
ajrhss-623	7	13	functional	functional	ADJ
ajrhss-623	7	14	and	and	CCONJ
ajrhss-623	7	15	organic	organic	ADJ
ajrhss-623	7	16	disorders	disorder	NOUN
ajrhss-623	7	17	of	of	ADP
ajrhss-623	7	18	the	the	DET
ajrhss-623	7	19	reproductive	reproductive	ADJ
ajrhss-623	7	20	system	system	NOUN
ajrhss-623	7	21	of	of	ADP
ajrhss-623	7	22	women	woman	NOUN
ajrhss-623	7	23	.	.	PUNCT
ajrhss-623	8	1	in	in	ADP
ajrhss-623	8	2	particular	particular	ADJ
ajrhss-623	8	3	,	,	PUNCT
ajrhss-623	8	4	one	one	NUM
ajrhss-623	8	5	of	of	ADP
ajrhss-623	8	6	the	the	DET
ajrhss-623	8	7	most	most	ADV
ajrhss-623	8	8	common	common	ADJ
ajrhss-623	8	9	causes	cause	NOUN
ajrhss-623	8	10	is	be	AUX
ajrhss-623	8	11	a	a	DET
ajrhss-623	8	12	violation	violation	NOUN
ajrhss-623	8	13	of	of	ADP
ajrhss-623	8	14	the	the	DET
ajrhss-623	8	15	ratio	ratio	NOUN
ajrhss-623	8	16	of	of	ADP
ajrhss-623	8	17	estrogens	estrogen	NOUN
ajrhss-623	8	18	and	and	CCONJ
ajrhss-623	8	19	progestogens	progestogen	NOUN
ajrhss-623	8	20	that	that	PRON
ajrhss-623	8	21	affect	affect	VERB
ajrhss-623	8	22	the	the	DET
ajrhss-623	8	23	target	target	NOUN
ajrhss-623	8	24	tissue	tissue	NOUN
ajrhss-623	8	25	the	the	DET
ajrhss-623	8	26	endometrium	endometrium	NOUN
ajrhss-623	8	27	,	,	PUNCT
ajrhss-623	8	28	therefore	therefore	ADV
ajrhss-623	8	29	,	,	PUNCT
ajrhss-623	8	30	according	accord	VERB
ajrhss-623	8	31	to	to	ADP
ajrhss-623	8	32	the	the	DET
ajrhss-623	8	33	classification	classification	NOUN
ajrhss-623	8	34	of	of	ADP
ajrhss-623	8	35	the	the	DET
ajrhss-623	8	36	international	international	PROPN
ajrhss-623	8	37	federation	federation	PROPN
ajrhss-623	8	38	of	of	ADP
ajrhss-623	8	39	gynecology	gynecology	NOUN
ajrhss-623	8	40	and	and	CCONJ
ajrhss-623	8	41	obstetrics	obstetric	NOUN
ajrhss-623	8	42	(	(	PUNCT
ajrhss-623	8	43	figo	figo	NOUN
ajrhss-623	8	44	)	)	PUNCT
ajrhss-623	8	45	,	,	PUNCT
ajrhss-623	8	46	they	they	PRON
ajrhss-623	8	47	are	be	AUX
ajrhss-623	8	48	registered	register	VERB
ajrhss-623	8	49	as	as	ADP
ajrhss-623	8	50	amk	amk	NOUN
ajrhss-623	8	51	-	-	PUNCT
ajrhss-623	8	52	o.	o.	PROPN
ajrhss-623	8	53	according	accord	VERB
ajrhss-623	8	54	to	to	ADP
ajrhss-623	8	55	the	the	DET
ajrhss-623	8	56	palm	palm	NOUN
ajrhss-623	8	57	-	-	PUNCT
ajrhss-623	8	58	coein	coein	NOUN
ajrhss-623	8	59	classification	classification	NOUN
ajrhss-623	8	60	system	system	NOUN
ajrhss-623	8	61	,	,	PUNCT
ajrhss-623	8	62	which	which	PRON
ajrhss-623	8	63	is	be	AUX
ajrhss-623	8	64	a	a	DET
ajrhss-623	8	65	mnemonic	mnemonic	NOUN
ajrhss-623	8	66	for	for	ADP
ajrhss-623	8	67	structural	structural	ADJ
ajrhss-623	8	68	(	(	PUNCT
ajrhss-623	8	69	palm	palm	NOUN
ajrhss-623	8	70	)	)	PUNCT
ajrhss-623	8	71	and	and	CCONJ
ajrhss-623	8	72	non	non	ADJ
ajrhss-623	8	73	-	-	ADJ
ajrhss-623	8	74	structural	structural	ADJ
ajrhss-623	8	75	(	(	PUNCT
ajrhss-623	8	76	coein	coein	PROPN
ajrhss-623	8	77	)	)	PUNCT
ajrhss-623	8	78	causes	cause	NOUN
ajrhss-623	8	79	of	of	ADP
ajrhss-623	8	80	abnormal	abnormal	ADJ
ajrhss-623	8	81	bleeding	bleeding	NOUN
ajrhss-623	8	82	,	,	PUNCT
ajrhss-623	8	83	non	non	ADJ
ajrhss-623	8	84	-	-	ADJ
ajrhss-623	8	85	gravid	gravid	ADJ
ajrhss-623	8	86	urgent	urgent	ADJ
ajrhss-623	8	87	uterine	uterine	NOUN
ajrhss-623	8	88	bleeding	bleed	VERB
ajrhss-623	8	89	due	due	ADP
ajrhss-623	8	90	to	to	ADP
ajrhss-623	8	91	ovulatory	ovulatory	ADJ
ajrhss-623	8	92	dysfunction	dysfunction	NOUN
ajrhss-623	8	93	(	(	PUNCT
ajrhss-623	8	94	aub	aub	NOUN
ajrhss-623	8	95	-	-	PUNCT
ajrhss-623	8	96	o	o	NOUN
ajrhss-623	8	97	)	)	PUNCT
ajrhss-623	8	98	is	be	AUX
ajrhss-623	8	99	abnormal	abnormal	ADJ
ajrhss-623	8	100	,	,	PUNCT
ajrhss-623	8	101	which	which	PRON
ajrhss-623	8	102	,	,	PUNCT
ajrhss-623	8	103	according	accord	VERB
ajrhss-623	8	104	to	to	ADP
ajrhss-623	8	105	gynecological	gynecological	ADJ
ajrhss-623	8	106	examination	examination	NOUN
ajrhss-623	8	107	and	and	CCONJ
ajrhss-623	8	108	ultrasound	ultrasound	NOUN
ajrhss-623	8	109	,	,	PUNCT
ajrhss-623	8	110	can	can	AUX
ajrhss-623	8	111	not	not	PART
ajrhss-623	8	112	be	be	AUX
ajrhss-623	8	113	explained	explain	VERB
ajrhss-623	8	114	by	by	ADP
ajrhss-623	8	115	the	the	DET
ajrhss-623	8	116	usual	usual	ADJ
ajrhss-623	8	117	causes	cause	NOUN
ajrhss-623	8	118	of	of	ADP
ajrhss-623	8	119	bleeding	bleed	VERB
ajrhss-623	8	120	(	(	PUNCT
ajrhss-623	8	121	structural	structural	ADJ
ajrhss-623	8	122	gynecological	gynecological	ADJ
ajrhss-623	8	123	abnormalities	abnormality	NOUN
ajrhss-623	8	124	,	,	PUNCT
ajrhss-623	8	125	cancer	cancer	NOUN
ajrhss-623	8	126	,	,	PUNCT
ajrhss-623	8	127	inflammation	inflammation	NOUN
ajrhss-623	8	128	,	,	PUNCT
ajrhss-623	8	129	systemic	systemic	ADJ
ajrhss-623	8	130	diseases	disease	NOUN
ajrhss-623	8	131	,	,	PUNCT
ajrhss-623	8	132	oral	oral	ADJ
ajrhss-623	8	133	contraceptives	contraceptive	NOUN
ajrhss-623	8	134	or	or	CCONJ
ajrhss-623	8	135	certain	certain	ADJ
ajrhss-623	8	136	drugs	drug	NOUN
ajrhss-623	8	137	)	)	PUNCT
ajrhss-623	8	138	.	.	PUNCT
ajrhss-623	9	1	abnormal	abnormal	ADJ
ajrhss-623	9	2	uterine	uterine	ADJ
ajrhss-623	9	3	bleeding	bleeding	NOUN
ajrhss-623	9	4	,	,	PUNCT
ajrhss-623	9	5	menorrhagia	menorrhagia	NOUN
ajrhss-623	9	6	,	,	PUNCT
ajrhss-623	9	7	anemia	anemia	NOUN
ajrhss-623	9	8	,	,	PUNCT
ajrhss-623	9	9	polycystic	polycystic	ADJ
ajrhss-623	9	10	ovary	ovary	ADJ
ajrhss-623	9	11	syndrome	syndrome	NOUN
ajrhss-623	9	12	,	,	PUNCT
ajrhss-623	9	13	adolescent	adolescent	ADJ
ajrhss-623	9	14	,	,	PUNCT
ajrhss-623	9	15	endometritis	endometritis	ADJ
ajrhss-623	9	16	introduction	introduction	NOUN
ajrhss-623	9	17	despite	despite	SCONJ
ajrhss-623	9	18	the	the	DET
ajrhss-623	9	19	significant	significant	ADJ
ajrhss-623	9	20	progress	progress	NOUN
ajrhss-623	9	21	made	make	VERB
ajrhss-623	9	22	over	over	ADP
ajrhss-623	9	23	the	the	DET
ajrhss-623	9	24	past	past	ADJ
ajrhss-623	9	25	decades	decade	NOUN
ajrhss-623	9	26	in	in	ADP
ajrhss-623	9	27	various	various	ADJ
ajrhss-623	9	28	areas	area	NOUN
ajrhss-623	9	29	of	of	ADP
ajrhss-623	9	30	obstetrics	obstetric	NOUN
ajrhss-623	9	31	and	and	CCONJ
ajrhss-623	9	32	gynecology	gynecology	NOUN
ajrhss-623	9	33	,	,	PUNCT
ajrhss-623	9	34	the	the	DET
ajrhss-623	9	35	problem	problem	NOUN
ajrhss-623	9	36	of	of	ADP
ajrhss-623	9	37	nongravid	nongravid	PROPN
ajrhss-623	9	38	urgency	urgency	NOUN
ajrhss-623	9	39	uterine	uterine	ADJ
ajrhss-623	9	40	bleeding	bleeding	NOUN
ajrhss-623	9	41	remains	remain	VERB
ajrhss-623	9	42	far	far	ADV
ajrhss-623	9	43	from	from	ADP
ajrhss-623	9	44	being	be	AUX
ajrhss-623	9	45	solved	solve	VERB
ajrhss-623	9	46	.	.	PUNCT
ajrhss-623	10	1	american	american	PROPN
ajrhss-623	10	2	journal	journal	PROPN
ajrhss-623	10	3	of	of	ADP
ajrhss-623	10	4	research	research	NOUN
ajrhss-623	10	5	in	in	ADP
ajrhss-623	10	6	humanities	humanity	NOUN
ajrhss-623	10	7	and	and	CCONJ
ajrhss-623	10	8	social	social	ADJ
ajrhss-623	10	9	sciences	science	NOUN
ajrhss-623	10	10	volume	volume	NOUN
ajrhss-623	10	11	11	11	NUM
ajrhss-623	10	12	,	,	PUNCT
ajrhss-623	10	13	april	april	PROPN
ajrhss-623	10	14	,	,	PUNCT
ajrhss-623	10	15	2023	2023	NUM
ajrhss-623	10	16	p	p	NOUN
ajrhss-623	10	17	a	a	PRON
ajrhss-623	10	18	g	g	NOUN
ajrhss-623	10	19	e	e	NOUN
ajrhss-623	10	20	|	|	ADV
ajrhss-623	10	21	67	67	NUM
ajrhss-623	10	22	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-623	10	23	often	often	ADV
ajrhss-623	10	24	,	,	PUNCT
ajrhss-623	10	25	in	in	ADP
ajrhss-623	10	26	uzbekistan	uzbekistan	PROPN
ajrhss-623	10	27	,	,	PUNCT
ajrhss-623	10	28	abnormal	abnormal	ADJ
ajrhss-623	10	29	uterine	uterine	ADJ
ajrhss-623	10	30	bleeding	bleeding	NOUN
ajrhss-623	10	31	is	be	AUX
ajrhss-623	10	32	one	one	NUM
ajrhss-623	10	33	of	of	ADP
ajrhss-623	10	34	the	the	DET
ajrhss-623	10	35	main	main	ADJ
ajrhss-623	10	36	causes	cause	NOUN
ajrhss-623	10	37	of	of	ADP
ajrhss-623	10	38	iron	iron	NOUN
ajrhss-623	10	39	deficiency	deficiency	NOUN
ajrhss-623	10	40	anemia	anemia	NOUN
ajrhss-623	10	41	,	,	PUNCT
ajrhss-623	10	42	reduces	reduce	VERB
ajrhss-623	10	43	the	the	DET
ajrhss-623	10	44	efficiency	efficiency	NOUN
ajrhss-623	10	45	and	and	CCONJ
ajrhss-623	10	46	quality	quality	NOUN
ajrhss-623	10	47	of	of	ADP
ajrhss-623	10	48	life	life	NOUN
ajrhss-623	10	49	of	of	ADP
ajrhss-623	10	50	women	woman	NOUN
ajrhss-623	10	51	,	,	PUNCT
ajrhss-623	10	52	and	and	CCONJ
ajrhss-623	10	53	also	also	ADV
ajrhss-623	10	54	occupies	occupy	VERB
ajrhss-623	10	55	one	one	NUM
ajrhss-623	10	56	of	of	ADP
ajrhss-623	10	57	the	the	DET
ajrhss-623	10	58	first	first	ADJ
ajrhss-623	10	59	places	place	NOUN
ajrhss-623	10	60	among	among	ADP
ajrhss-623	10	61	the	the	DET
ajrhss-623	10	62	causes	cause	NOUN
ajrhss-623	10	63	of	of	ADP
ajrhss-623	10	64	hospitalization	hospitalization	NOUN
ajrhss-623	10	65	of	of	ADP
ajrhss-623	10	66	women	woman	NOUN
ajrhss-623	10	67	in	in	ADP
ajrhss-623	10	68	gynecological	gynecological	ADJ
ajrhss-623	10	69	hospitals	hospital	NOUN
ajrhss-623	10	70	and	and	CCONJ
ajrhss-623	10	71	serves	serve	VERB
ajrhss-623	10	72	as	as	ADP
ajrhss-623	10	73	an	an	DET
ajrhss-623	10	74	indication	indication	NOUN
ajrhss-623	10	75	for	for	ADP
ajrhss-623	10	76	surgical	surgical	ADJ
ajrhss-623	10	77	intervention	intervention	NOUN
ajrhss-623	10	78	.	.	PUNCT
ajrhss-623	11	1	purpose	purpose	NOUN
ajrhss-623	11	2	of	of	ADP
ajrhss-623	11	3	the	the	DET
ajrhss-623	11	4	study	study	NOUN
ajrhss-623	11	5	:	:	PUNCT
ajrhss-623	11	6	to	to	PART
ajrhss-623	11	7	analyze	analyze	VERB
ajrhss-623	11	8	the	the	DET
ajrhss-623	11	9	literature	literature	NOUN
ajrhss-623	11	10	on	on	ADP
ajrhss-623	11	11	diagnostics	diagnostic	NOUN
ajrhss-623	11	12	and	and	CCONJ
ajrhss-623	11	13	management	management	NOUN
ajrhss-623	11	14	of	of	ADP
ajrhss-623	11	15	non	non	ADJ
ajrhss-623	11	16	-	-	ADJ
ajrhss-623	11	17	gravidary	gravidary	ADJ
ajrhss-623	11	18	urgent	urgent	ADJ
ajrhss-623	11	19	uterine	uterine	ADJ
ajrhss-623	11	20	bleeding	bleeding	NOUN
ajrhss-623	11	21	according	accord	VERB
ajrhss-623	11	22	to	to	ADP
ajrhss-623	11	23	international	international	ADJ
ajrhss-623	11	24	recommendations	recommendation	NOUN
ajrhss-623	11	25	.	.	PUNCT
ajrhss-623	12	1	results	result	NOUN
ajrhss-623	12	2	aub	aub	PROPN
ajrhss-623	12	3	can	can	AUX
ajrhss-623	12	4	be	be	AUX
ajrhss-623	12	5	manifested	manifest	VERB
ajrhss-623	12	6	by	by	ADP
ajrhss-623	12	7	regular	regular	ADJ
ajrhss-623	12	8	,	,	PUNCT
ajrhss-623	12	9	prolonged	prolong	VERB
ajrhss-623	12	10	(	(	PUNCT
ajrhss-623	12	11	more	more	ADJ
ajrhss-623	12	12	than	than	ADP
ajrhss-623	12	13	8	8	NUM
ajrhss-623	12	14	days	day	NOUN
ajrhss-623	12	15	)	)	PUNCT
ajrhss-623	12	16	and	and	CCONJ
ajrhss-623	12	17	heavy	heavy	ADJ
ajrhss-623	12	18	(	(	PUNCT
ajrhss-623	12	19	more	more	ADJ
ajrhss-623	12	20	than	than	ADP
ajrhss-623	12	21	80	80	NUM
ajrhss-623	12	22	ml	ml	NOUN
ajrhss-623	12	23	)	)	PUNCT
ajrhss-623	12	24	menstrual	menstrual	ADJ
ajrhss-623	12	25	bleeding	bleeding	NOUN
ajrhss-623	12	26	(	(	PUNCT
ajrhss-623	12	27	mbb	mbb	PROPN
ajrhss-623	12	28	)	)	PUNCT
ajrhss-623	12	29	.	.	PUNCT
ajrhss-623	13	1	the	the	DET
ajrhss-623	13	2	causes	cause	NOUN
ajrhss-623	13	3	of	of	ADP
ajrhss-623	13	4	these	these	DET
ajrhss-623	13	5	bleedings	bleeding	NOUN
ajrhss-623	13	6	are	be	AUX
ajrhss-623	13	7	more	more	ADV
ajrhss-623	13	8	often	often	ADV
ajrhss-623	13	9	adenomyosis	adenomyosis	NOUN
ajrhss-623	13	10	,	,	PUNCT
ajrhss-623	13	11	submucosal	submucosal	NOUN
ajrhss-623	13	12	uterine	uterine	NOUN
ajrhss-623	13	13	myoma	myoma	PROPN
ajrhss-623	13	14	,	,	PUNCT
ajrhss-623	13	15	coagulopathy	coagulopathy	ADJ
ajrhss-623	13	16	,	,	PUNCT
ajrhss-623	13	17	functional	functional	ADJ
ajrhss-623	13	18	disorders	disorder	NOUN
ajrhss-623	13	19	of	of	ADP
ajrhss-623	13	20	the	the	DET
ajrhss-623	13	21	endometrium	endometrium	NOUN
ajrhss-623	13	22	.	.	PUNCT
ajrhss-623	14	1	intermenstrual	intermenstrual	ADJ
ajrhss-623	14	2	bleeding	bleeding	NOUN
ajrhss-623	14	3	(	(	PUNCT
ajrhss-623	14	4	imb	imb	PROPN
ajrhss-623	14	5	)	)	PUNCT
ajrhss-623	14	6	against	against	ADP
ajrhss-623	14	7	the	the	DET
ajrhss-623	14	8	background	background	NOUN
ajrhss-623	14	9	of	of	ADP
ajrhss-623	14	10	a	a	DET
ajrhss-623	14	11	regular	regular	ADJ
ajrhss-623	14	12	cycle	cycle	NOUN
ajrhss-623	14	13	is	be	AUX
ajrhss-623	14	14	characteristic	characteristic	ADJ
ajrhss-623	14	15	of	of	ADP
ajrhss-623	14	16	endometrial	endometrial	ADJ
ajrhss-623	14	17	polyps	polyp	NOUN
ajrhss-623	14	18	,	,	PUNCT
ajrhss-623	14	19	chronic	chronic	ADJ
ajrhss-623	14	20	endometritis	endometritis	NOUN
ajrhss-623	14	21	,	,	PUNCT
ajrhss-623	14	22	ovulatory	ovulatory	ADJ
ajrhss-623	14	23	dysfunction	dysfunction	NOUN
ajrhss-623	14	24	.	.	PUNCT
ajrhss-623	15	1	irregular	irregular	ADJ
ajrhss-623	15	2	,	,	PUNCT
ajrhss-623	15	3	unpredictable	unpredictable	ADJ
ajrhss-623	15	4	prolonged	prolonged	ADJ
ajrhss-623	15	5	and	and	CCONJ
ajrhss-623	15	6	/	/	SYM
ajrhss-623	15	7	or	or	CCONJ
ajrhss-623	15	8	profuse	profuse	VERB
ajrhss-623	15	9	bleeding	bleeding	NOUN
ajrhss-623	15	10	,	,	PUNCT
ajrhss-623	15	11	more	more	ADV
ajrhss-623	15	12	often	often	ADV
ajrhss-623	15	13	occurring	occur	VERB
ajrhss-623	15	14	after	after	ADP
ajrhss-623	15	15	menstruation	menstruation	NOUN
ajrhss-623	15	16	delays	delay	NOUN
ajrhss-623	15	17	,	,	PUNCT
ajrhss-623	15	18	is	be	AUX
ajrhss-623	15	19	more	more	ADV
ajrhss-623	15	20	characteristic	characteristic	ADJ
ajrhss-623	15	21	of	of	ADP
ajrhss-623	15	22	hyperplasia	hyperplasia	NOUN
ajrhss-623	15	23	and	and	CCONJ
ajrhss-623	15	24	endometrial	endometrial	ADJ
ajrhss-623	15	25	cancer	cancer	NOUN
ajrhss-623	15	26	.	.	PUNCT
ajrhss-623	16	1	to	to	PART
ajrhss-623	16	2	select	select	VERB
ajrhss-623	16	3	a	a	DET
ajrhss-623	16	4	rational	rational	ADJ
ajrhss-623	16	5	management	management	NOUN
ajrhss-623	16	6	tactic	tactic	NOUN
ajrhss-623	16	7	,	,	PUNCT
ajrhss-623	16	8	it	it	PRON
ajrhss-623	16	9	is	be	AUX
ajrhss-623	16	10	necessary	necessary	ADJ
ajrhss-623	16	11	to	to	PART
ajrhss-623	16	12	establish	establish	VERB
ajrhss-623	16	13	the	the	DET
ajrhss-623	16	14	cause	cause	NOUN
ajrhss-623	16	15	of	of	ADP
ajrhss-623	16	16	aub	aub	NOUN
ajrhss-623	16	17	and	and	CCONJ
ajrhss-623	16	18	attribute	attribute	VERB
ajrhss-623	16	19	it	it	PRON
ajrhss-623	16	20	to	to	ADP
ajrhss-623	16	21	one	one	NUM
ajrhss-623	16	22	of	of	ADP
ajrhss-623	16	23	the	the	DET
ajrhss-623	16	24	above	above	ADJ
ajrhss-623	16	25	categories	category	NOUN
ajrhss-623	16	26	.	.	PUNCT
ajrhss-623	17	1	assessment	assessment	NOUN
ajrhss-623	17	2	of	of	ADP
ajrhss-623	17	3	the	the	DET
ajrhss-623	17	4	amount	amount	NOUN
ajrhss-623	17	5	of	of	ADP
ajrhss-623	17	6	blood	blood	NOUN
ajrhss-623	17	7	loss	loss	NOUN
ajrhss-623	17	8	is	be	AUX
ajrhss-623	17	9	carried	carry	VERB
ajrhss-623	17	10	out	out	ADP
ajrhss-623	17	11	according	accord	VERB
ajrhss-623	17	12	to	to	ADP
ajrhss-623	17	13	clinical	clinical	ADJ
ajrhss-623	17	14	indicators	indicator	NOUN
ajrhss-623	17	15	or	or	CCONJ
ajrhss-623	17	16	a	a	DET
ajrhss-623	17	17	scoring	scoring	NOUN
ajrhss-623	17	18	scale	scale	NOUN
ajrhss-623	17	19	(	(	PUNCT
ajrhss-623	17	20	menstrual	menstrual	ADJ
ajrhss-623	17	21	blood	blood	NOUN
ajrhss-623	17	22	loss	loss	NOUN
ajrhss-623	17	23	pictogram	pictogram	PROPN
ajrhss-623	17	24	)	)	PUNCT
ajrhss-623	17	25	;	;	PUNCT
ajrhss-623	17	26	an	an	DET
ajrhss-623	17	27	objective	objective	ADJ
ajrhss-623	17	28	alkaline	alkaline	NOUN
ajrhss-623	17	29	-	-	PUNCT
ajrhss-623	17	30	hematin	hematin	NOUN
ajrhss-623	17	31	test	test	NOUN
ajrhss-623	17	32	is	be	AUX
ajrhss-623	17	33	used	use	VERB
ajrhss-623	17	34	in	in	ADP
ajrhss-623	17	35	the	the	DET
ajrhss-623	17	36	conduct	conduct	NOUN
ajrhss-623	17	37	of	of	ADP
ajrhss-623	17	38	scientific	scientific	ADJ
ajrhss-623	17	39	research	research	NOUN
ajrhss-623	17	40	.	.	PUNCT
ajrhss-623	18	1	according	accord	VERB
ajrhss-623	18	2	to	to	ADP
ajrhss-623	18	3	international	international	ADJ
ajrhss-623	18	4	recommendations	recommendation	NOUN
ajrhss-623	18	5	for	for	ADP
ajrhss-623	18	6	aub	aub	NOUN
ajrhss-623	18	7	,	,	PUNCT
ajrhss-623	18	8	laboratory	laboratory	NOUN
ajrhss-623	18	9	diagnostics	diagnostic	NOUN
ajrhss-623	18	10	should	should	AUX
ajrhss-623	18	11	include	include	VERB
ajrhss-623	18	12	:	:	PUNCT
ajrhss-623	18	13	•	•	NUM
ajrhss-623	18	14	determination	determination	NOUN
ajrhss-623	18	15	of	of	ADP
ajrhss-623	18	16	the	the	DET
ajrhss-623	18	17	level	level	NOUN
ajrhss-623	18	18	of	of	ADP
ajrhss-623	18	19	β	β	NOUN
ajrhss-623	18	20	-	-	NOUN
ajrhss-623	18	21	chg	chg	NOUN
ajrhss-623	18	22	in	in	ADP
ajrhss-623	18	23	the	the	DET
ajrhss-623	18	24	blood	blood	NOUN
ajrhss-623	18	25	serum	serum	NOUN
ajrhss-623	18	26	(	(	PUNCT
ajrhss-623	18	27	with	with	ADP
ajrhss-623	18	28	•	•	NUM
ajrhss-623	18	29	suspicion	suspicion	NOUN
ajrhss-623	18	30	of	of	ADP
ajrhss-623	18	31	pregnancy	pregnancy	NOUN
ajrhss-623	18	32	)	)	PUNCT
ajrhss-623	18	33	;	;	PUNCT
ajrhss-623	18	34	•	•	NUM
ajrhss-623	18	35	examination	examination	NOUN
ajrhss-623	18	36	for	for	ADP
ajrhss-623	18	37	the	the	DET
ajrhss-623	18	38	presence	presence	NOUN
ajrhss-623	18	39	of	of	ADP
ajrhss-623	18	40	anemia	anemia	NOUN
ajrhss-623	18	41	(	(	PUNCT
ajrhss-623	18	42	clinical	clinical	ADJ
ajrhss-623	18	43	blood	blood	NOUN
ajrhss-623	18	44	test	test	NOUN
ajrhss-623	18	45	,	,	PUNCT
ajrhss-623	18	46	including	include	VERB
ajrhss-623	18	47	platelets	platelet	NOUN
ajrhss-623	18	48	)	)	PUNCT
ajrhss-623	18	49	;	;	PUNCT
ajrhss-623	18	50	•	•	NUM
ajrhss-623	18	51	coagulogram	coagulogram	PROPN
ajrhss-623	18	52	,	,	PUNCT
ajrhss-623	18	53	if	if	SCONJ
ajrhss-623	18	54	a	a	DET
ajrhss-623	18	55	pathology	pathology	NOUN
ajrhss-623	18	56	of	of	ADP
ajrhss-623	18	57	hemostasis	hemostasis	NOUN
ajrhss-623	18	58	is	be	AUX
ajrhss-623	18	59	suspected	suspect	VERB
ajrhss-623	18	60	,	,	PUNCT
ajrhss-623	18	61	a	a	DET
ajrhss-623	18	62	consultation	consultation	NOUN
ajrhss-623	18	63	with	with	ADP
ajrhss-623	18	64	a	a	DET
ajrhss-623	18	65	hematologist	hematologist	NOUN
ajrhss-623	18	66	and	and	CCONJ
ajrhss-623	18	67	a	a	DET
ajrhss-623	18	68	special	special	ADJ
ajrhss-623	18	69	examination	examination	NOUN
ajrhss-623	18	70	(	(	PUNCT
ajrhss-623	18	71	for	for	ADP
ajrhss-623	18	72	von	von	PROPN
ajrhss-623	18	73	willebrand	willebrand	PROPN
ajrhss-623	18	74	disease	disease	NOUN
ajrhss-623	18	75	determination	determination	NOUN
ajrhss-623	18	76	of	of	ADP
ajrhss-623	18	77	factor	factor	NOUN
ajrhss-623	18	78	viii	viii	NOUN
ajrhss-623	18	79	,	,	PUNCT
ajrhss-623	18	80	ristocetin	ristocetin	NOUN
ajrhss-623	18	81	cofactor	cofactor	NOUN
ajrhss-623	18	82	,	,	PUNCT
ajrhss-623	18	83	factor	factor	NOUN
ajrhss-623	18	84	antigen	antigen	ADJ
ajrhss-623	18	85	•	•	NOUN
ajrhss-623	18	86	willebrand	willebrand	NOUN
ajrhss-623	18	87	)	)	PUNCT
ajrhss-623	18	88	.	.	PUNCT
ajrhss-623	19	1	hormonal	hormonal	ADJ
ajrhss-623	19	2	examination	examination	NOUN
ajrhss-623	19	3	is	be	AUX
ajrhss-623	19	4	carried	carry	VERB
ajrhss-623	19	5	out	out	ADP
ajrhss-623	19	6	with	with	ADP
ajrhss-623	19	7	an	an	DET
ajrhss-623	19	8	irregular	irregular	ADJ
ajrhss-623	19	9	rhythm	rhythm	NOUN
ajrhss-623	19	10	of	of	ADP
ajrhss-623	19	11	menstruation	menstruation	NOUN
ajrhss-623	19	12	and	and	CCONJ
ajrhss-623	19	13	the	the	DET
ajrhss-623	19	14	risk	risk	NOUN
ajrhss-623	19	15	of	of	ADP
ajrhss-623	19	16	hypothyroidism	hypothyroidism	NOUN
ajrhss-623	19	17	(	(	PUNCT
ajrhss-623	19	18	determination	determination	NOUN
ajrhss-623	19	19	of	of	ADP
ajrhss-623	19	20	the	the	DET
ajrhss-623	19	21	level	level	NOUN
ajrhss-623	19	22	of	of	ADP
ajrhss-623	19	23	tsh	tsh	NOUN
ajrhss-623	19	24	,	,	PUNCT
ajrhss-623	19	25	progesterone	progesterone	NOUN
ajrhss-623	19	26	)	)	PUNCT
ajrhss-623	19	27	;	;	PUNCT
ajrhss-623	19	28	testing	test	VERB
ajrhss-623	19	29	for	for	ADP
ajrhss-623	19	30	chlamydial	chlamydial	ADJ
ajrhss-623	19	31	infection	infection	NOUN
ajrhss-623	19	32	(	(	PUNCT
ajrhss-623	19	33	at	at	ADP
ajrhss-623	19	34	high	high	ADJ
ajrhss-623	19	35	infectious	infectious	ADJ
ajrhss-623	19	36	risk	risk	NOUN
ajrhss-623	19	37	)	)	PUNCT
ajrhss-623	19	38	;	;	PUNCT
ajrhss-623	19	39	a	a	DET
ajrhss-623	19	40	pap	pap	NOUN
ajrhss-623	19	41	test	test	NOUN
ajrhss-623	19	42	is	be	AUX
ajrhss-623	19	43	performed	perform	VERB
ajrhss-623	19	44	to	to	PART
ajrhss-623	19	45	rule	rule	VERB
ajrhss-623	19	46	out	out	ADP
ajrhss-623	19	47	cervical	cervical	ADJ
ajrhss-623	19	48	pathology	pathology	NOUN
ajrhss-623	19	49	.	.	PUNCT
ajrhss-623	20	1	the	the	DET
ajrhss-623	20	2	recommendations	recommendation	NOUN
ajrhss-623	20	3	of	of	ADP
ajrhss-623	20	4	the	the	DET
ajrhss-623	20	5	american	american	ADJ
ajrhss-623	20	6	and	and	CCONJ
ajrhss-623	20	7	canadian	canadian	ADJ
ajrhss-623	20	8	colleges	college	NOUN
ajrhss-623	20	9	of	of	ADP
ajrhss-623	20	10	obstetricians	obstetrician	NOUN
ajrhss-623	20	11	and	and	CCONJ
ajrhss-623	20	12	gynecologists	gynecologist	NOUN
ajrhss-623	20	13	(	(	PUNCT
ajrhss-623	20	14	2013	2013	NUM
ajrhss-623	20	15	)	)	PUNCT
ajrhss-623	20	16	provide	provide	VERB
ajrhss-623	20	17	an	an	DET
ajrhss-623	20	18	algorithm	algorithm	NOUN
ajrhss-623	20	19	for	for	ADP
ajrhss-623	20	20	examining	examine	VERB
ajrhss-623	20	21	patients	patient	NOUN
ajrhss-623	20	22	with	with	ADP
ajrhss-623	20	23	aub	aub	PROPN
ajrhss-623	20	24	.	.	PUNCT
ajrhss-623	20	25	transvaginal	transvaginal	ADJ
ajrhss-623	20	26	ultrasound	ultrasound	NOUN
ajrhss-623	20	27	examination	examination	NOUN
ajrhss-623	20	28	(	(	PUNCT
ajrhss-623	20	29	ultrasound	ultrasound	NOUN
ajrhss-623	20	30	)	)	PUNCT
ajrhss-623	20	31	of	of	ADP
ajrhss-623	20	32	the	the	DET
ajrhss-623	20	33	pelvic	pelvic	ADJ
ajrhss-623	20	34	organs	organ	NOUN
ajrhss-623	20	35	is	be	AUX
ajrhss-623	20	36	considered	consider	VERB
ajrhss-623	20	37	as	as	ADP
ajrhss-623	20	38	a	a	DET
ajrhss-623	20	39	1st	1st	ADJ
ajrhss-623	20	40	line	line	NOUN
ajrhss-623	20	41	diagnostic	diagnostic	ADJ
ajrhss-623	20	42	procedure	procedure	NOUN
ajrhss-623	20	43	for	for	ADP
ajrhss-623	20	44	assessing	assess	VERB
ajrhss-623	20	45	the	the	DET
ajrhss-623	20	46	state	state	NOUN
ajrhss-623	20	47	of	of	ADP
ajrhss-623	20	48	the	the	DET
ajrhss-623	20	49	endometrium	endometrium	NOUN
ajrhss-623	20	50	(	(	PUNCT
ajrhss-623	20	51	higher	high	ADJ
ajrhss-623	20	52	information	information	NOUN
ajrhss-623	20	53	content	content	NOUN
ajrhss-623	20	54	in	in	ADP
ajrhss-623	20	55	postmenopausal	postmenopausal	ADJ
ajrhss-623	20	56	women	woman	NOUN
ajrhss-623	20	57	)	)	PUNCT
ajrhss-623	20	58	.	.	PUNCT
ajrhss-623	21	1	dopplerometry	dopplerometry	NOUN
ajrhss-623	21	2	provides	provide	VERB
ajrhss-623	21	3	only	only	ADV
ajrhss-623	21	4	additional	additional	ADJ
ajrhss-623	21	5	information	information	NOUN
ajrhss-623	21	6	about	about	ADP
ajrhss-623	21	7	the	the	DET
ajrhss-623	21	8	nature	nature	NOUN
ajrhss-623	21	9	of	of	ADP
ajrhss-623	21	10	the	the	DET
ajrhss-623	21	11	pathology	pathology	NOUN
ajrhss-623	21	12	of	of	ADP
ajrhss-623	21	13	the	the	DET
ajrhss-623	21	14	endometrium	endometrium	NOUN
ajrhss-623	21	15	and	and	CCONJ
ajrhss-623	21	16	myometrium	myometrium	NOUN
ajrhss-623	21	17	.	.	PUNCT
ajrhss-623	22	1	sonohysterography	sonohysterography	NOUN
ajrhss-623	22	2	is	be	AUX
ajrhss-623	22	3	of	of	ADP
ajrhss-623	22	4	high	high	ADJ
ajrhss-623	22	5	diagnostic	diagnostic	ADJ
ajrhss-623	22	6	value	value	NOUN
ajrhss-623	22	7	,	,	PUNCT
ajrhss-623	22	8	which	which	PRON
ajrhss-623	22	9	is	be	AUX
ajrhss-623	22	10	performed	perform	VERB
ajrhss-623	22	11	when	when	SCONJ
ajrhss-623	22	12	transvaginal	transvaginal	ADJ
ajrhss-623	22	13	ultrasound	ultrasound	NOUN
ajrhss-623	22	14	is	be	AUX
ajrhss-623	22	15	insufficiently	insufficiently	ADV
ajrhss-623	22	16	informative	informative	ADJ
ajrhss-623	22	17	to	to	PART
ajrhss-623	22	18	clarify	clarify	VERB
ajrhss-623	22	19	focal	focal	ADJ
ajrhss-623	22	20	intrauterine	intrauterine	ADJ
ajrhss-623	22	21	pathology	pathology	NOUN
ajrhss-623	22	22	.	.	PUNCT
ajrhss-623	23	1	mri	mri	NOUN
ajrhss-623	23	2	is	be	AUX
ajrhss-623	23	3	not	not	PART
ajrhss-623	23	4	considered	consider	VERB
ajrhss-623	23	5	as	as	ADP
ajrhss-623	23	6	a	a	DET
ajrhss-623	23	7	1st	1st	ADJ
ajrhss-623	23	8	line	line	NOUN
ajrhss-623	23	9	diagnostic	diagnostic	ADJ
ajrhss-623	23	10	procedure	procedure	NOUN
ajrhss-623	23	11	for	for	ADP
ajrhss-623	23	12	aub	aub	NOUN
ajrhss-623	23	13	,	,	PUNCT
ajrhss-623	23	14	it	it	PRON
ajrhss-623	23	15	is	be	AUX
ajrhss-623	23	16	recommended	recommend	VERB
ajrhss-623	23	17	for	for	ADP
ajrhss-623	23	18	multiple	multiple	ADJ
ajrhss-623	23	19	uterine	uterine	ADJ
ajrhss-623	23	20	myoma	myoma	NOUN
ajrhss-623	23	21	to	to	PART
ajrhss-623	23	22	clarify	clarify	VERB
ajrhss-623	23	23	the	the	DET
ajrhss-623	23	24	topography	topography	NOUN
ajrhss-623	23	25	of	of	ADP
ajrhss-623	23	26	nodes	node	NOUN
ajrhss-623	23	27	before	before	ADP
ajrhss-623	23	28	myoma	myoma	PROPN
ajrhss-623	23	29	ctomy	ctomy	NOUN
ajrhss-623	23	30	,	,	PUNCT
ajrhss-623	23	31	uterine	uterine	ADJ
ajrhss-623	23	32	artery	artery	NOUN
ajrhss-623	23	33	embolization	embolization	NOUN
ajrhss-623	23	34	,	,	PUNCT
ajrhss-623	23	35	fus	fus	ADJ
ajrhss-623	23	36	ablation	ablation	NOUN
ajrhss-623	23	37	,	,	PUNCT
ajrhss-623	23	38	as	as	ADV
ajrhss-623	23	39	well	well	ADV
ajrhss-623	23	40	as	as	ADP
ajrhss-623	23	41	in	in	ADP
ajrhss-623	23	42	cases	case	NOUN
ajrhss-623	23	43	of	of	ADP
ajrhss-623	23	44	suspected	suspect	VERB
ajrhss-623	23	45	adenomyosis	adenomyosis	NOUN
ajrhss-623	23	46	or	or	CCONJ
ajrhss-623	23	47	in	in	ADP
ajrhss-623	23	48	cases	case	NOUN
ajrhss-623	23	49	of	of	ADP
ajrhss-623	23	50	poor	poor	ADJ
ajrhss-623	23	51	visualization	visualization	NOUN
ajrhss-623	23	52	of	of	ADP
ajrhss-623	23	53	the	the	DET
ajrhss-623	23	54	uterine	uterine	ADJ
ajrhss-623	23	55	cavity	cavity	NOUN
ajrhss-623	23	56	to	to	PART
ajrhss-623	23	57	assess	assess	VERB
ajrhss-623	23	58	the	the	DET
ajrhss-623	23	59	condition	condition	NOUN
ajrhss-623	23	60	of	of	ADP
ajrhss-623	23	61	the	the	DET
ajrhss-623	23	62	endometrium	endometrium	NOUN
ajrhss-623	23	63	.	.	PUNCT
ajrhss-623	24	1	hysteroscopy	hysteroscopy	NOUN
ajrhss-623	24	2	and	and	CCONJ
ajrhss-623	24	3	endometrial	endometrial	ADJ
ajrhss-623	24	4	biopsy	biopsy	NOUN
ajrhss-623	24	5	continue	continue	VERB
ajrhss-623	24	6	to	to	PART
ajrhss-623	24	7	be	be	AUX
ajrhss-623	24	8	considered	consider	VERB
ajrhss-623	24	9	the	the	DET
ajrhss-623	24	10	"	"	PUNCT
ajrhss-623	24	11	gold	gold	ADJ
ajrhss-623	24	12	standard	standard	NOUN
ajrhss-623	24	13	"	"	PUNCT
ajrhss-623	24	14	american	american	ADJ
ajrhss-623	24	15	journal	journal	PROPN
ajrhss-623	24	16	of	of	ADP
ajrhss-623	24	17	research	research	NOUN
ajrhss-623	24	18	in	in	ADP
ajrhss-623	24	19	humanities	humanity	NOUN
ajrhss-623	24	20	and	and	CCONJ
ajrhss-623	24	21	social	social	ADJ
ajrhss-623	24	22	sciences	science	NOUN
ajrhss-623	24	23	volume	volume	NOUN
ajrhss-623	24	24	11	11	NUM
ajrhss-623	24	25	,	,	PUNCT
ajrhss-623	24	26	april	april	PROPN
ajrhss-623	24	27	,	,	PUNCT
ajrhss-623	24	28	2023	2023	NUM
ajrhss-623	24	29	p	p	NOUN
ajrhss-623	25	1	a	a	DET
ajrhss-623	25	2	g	g	NOUN
ajrhss-623	25	3	e	e	NOUN
ajrhss-623	25	4	|	|	ADV
ajrhss-623	25	5	68	68	NUM
ajrhss-623	25	6	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-623	25	7	for	for	ADP
ajrhss-623	25	8	diagnosing	diagnose	VERB
ajrhss-623	25	9	intrauterine	intrauterine	ADJ
ajrhss-623	25	10	pathology	pathology	NOUN
ajrhss-623	25	11	,	,	PUNCT
ajrhss-623	25	12	primarily	primarily	ADV
ajrhss-623	25	13	to	to	PART
ajrhss-623	25	14	exclude	exclude	VERB
ajrhss-623	25	15	precancerous	precancerous	ADJ
ajrhss-623	25	16	lesions	lesion	NOUN
ajrhss-623	25	17	and	and	CCONJ
ajrhss-623	25	18	endometrial	endometrial	ADJ
ajrhss-623	25	19	cancer	cancer	NOUN
ajrhss-623	25	20	.	.	PUNCT
ajrhss-623	26	1	recommended	recommend	VERB
ajrhss-623	26	2	for	for	ADP
ajrhss-623	26	3	suspected	suspect	VERB
ajrhss-623	26	4	pathology	pathology	NOUN
ajrhss-623	26	5	of	of	ADP
ajrhss-623	26	6	the	the	DET
ajrhss-623	26	7	endometrium	endometrium	NOUN
ajrhss-623	26	8	,	,	PUNCT
ajrhss-623	26	9	the	the	DET
ajrhss-623	26	10	presence	presence	NOUN
ajrhss-623	26	11	of	of	ADP
ajrhss-623	26	12	risk	risk	NOUN
ajrhss-623	26	13	factors	factor	NOUN
ajrhss-623	26	14	for	for	ADP
ajrhss-623	26	15	cancer	cancer	NOUN
ajrhss-623	26	16	of	of	ADP
ajrhss-623	26	17	the	the	DET
ajrhss-623	26	18	uterine	uterine	ADJ
ajrhss-623	26	19	body	body	NOUN
ajrhss-623	26	20	(	(	PUNCT
ajrhss-623	26	21	obesity	obesity	NOUN
ajrhss-623	26	22	,	,	PUNCT
ajrhss-623	26	23	polycystic	polycystic	ADJ
ajrhss-623	26	24	ovary	ovary	ADJ
ajrhss-623	26	25	syndrome	syndrome	NOUN
ajrhss-623	26	26	,	,	PUNCT
ajrhss-623	26	27	diabetes	diabetes	NOUN
ajrhss-623	26	28	mellitus	mellitus	NOUN
ajrhss-623	26	29	,	,	PUNCT
ajrhss-623	26	30	family	family	NOUN
ajrhss-623	26	31	history	history	NOUN
ajrhss-623	26	32	of	of	ADP
ajrhss-623	26	33	colon	colon	NOUN
ajrhss-623	26	34	cancer	cancer	NOUN
ajrhss-623	26	35	)	)	PUNCT
ajrhss-623	26	36	,	,	PUNCT
ajrhss-623	26	37	in	in	ADP
ajrhss-623	26	38	patients	patient	NOUN
ajrhss-623	26	39	with	with	ADP
ajrhss-623	26	40	aub	aub	PROPN
ajrhss-623	26	41	after	after	ADP
ajrhss-623	26	42	40	40	NUM
ajrhss-623	26	43	years	year	NOUN
ajrhss-623	26	44	.	.	PUNCT
ajrhss-623	27	1	office	office	NOUN
ajrhss-623	27	2	hysteroscopy	hysteroscopy	NOUN
ajrhss-623	27	3	and	and	CCONJ
ajrhss-623	27	4	aspiration	aspiration	NOUN
ajrhss-623	27	5	biopsy	biopsy	NOUN
ajrhss-623	27	6	are	be	AUX
ajrhss-623	27	7	preferred	prefer	VERB
ajrhss-623	27	8	as	as	ADP
ajrhss-623	27	9	less	less	ADV
ajrhss-623	27	10	traumatic	traumatic	ADJ
ajrhss-623	27	11	and	and	CCONJ
ajrhss-623	27	12	more	more	ADV
ajrhss-623	27	13	economical	economical	ADJ
ajrhss-623	27	14	procedures	procedure	NOUN
ajrhss-623	27	15	.	.	PUNCT
ajrhss-623	28	1	treatment	treatment	NOUN
ajrhss-623	28	2	of	of	ADP
ajrhss-623	28	3	aub	aub	PROPN
ajrhss-623	28	4	is	be	AUX
ajrhss-623	28	5	carried	carry	VERB
ajrhss-623	28	6	out	out	ADP
ajrhss-623	28	7	in	in	ADP
ajrhss-623	28	8	a	a	DET
ajrhss-623	28	9	differentiated	differentiated	ADJ
ajrhss-623	28	10	manner	manner	NOUN
ajrhss-623	28	11	,	,	PUNCT
ajrhss-623	28	12	in	in	ADP
ajrhss-623	28	13	accordance	accordance	NOUN
ajrhss-623	28	14	with	with	ADP
ajrhss-623	28	15	the	the	DET
ajrhss-623	28	16	identified	identify	VERB
ajrhss-623	28	17	pathology	pathology	NOUN
ajrhss-623	28	18	.	.	PUNCT
ajrhss-623	29	1	in	in	ADP
ajrhss-623	29	2	case	case	NOUN
ajrhss-623	29	3	of	of	ADP
ajrhss-623	29	4	aub	aub	NUM
ajrhss-623	29	5	not	not	PART
ajrhss-623	29	6	associated	associate	VERB
ajrhss-623	29	7	with	with	ADP
ajrhss-623	29	8	organic	organic	ADJ
ajrhss-623	29	9	pathology	pathology	NOUN
ajrhss-623	29	10	(	(	PUNCT
ajrhss-623	29	11	amk	amk	PROPN
ajrhss-623	29	12	-	-	PUNCT
ajrhss-623	29	13	o	o	PROPN
ajrhss-623	29	14	,	,	PUNCT
ajrhss-623	29	15	c	c	X
ajrhss-623	29	16	,	,	PUNCT
ajrhss-623	29	17	e	e	NOUN
ajrhss-623	29	18	,	,	PUNCT
ajrhss-623	29	19	n	n	CCONJ
ajrhss-623	29	20	)	)	PUNCT
ajrhss-623	29	21	,	,	PUNCT
ajrhss-623	29	22	drug	drug	NOUN
ajrhss-623	29	23	therapy	therapy	NOUN
ajrhss-623	29	24	is	be	AUX
ajrhss-623	29	25	prescribed	prescribe	VERB
ajrhss-623	29	26	:	:	PUNCT
ajrhss-623	29	27	non	non	ADJ
ajrhss-623	29	28	-	-	ADJ
ajrhss-623	29	29	hormonal	hormonal	ADJ
ajrhss-623	29	30	drugs	drug	NOUN
ajrhss-623	29	31	[	[	X
ajrhss-623	29	32	non	non	ADJ
ajrhss-623	29	33	-	-	ADJ
ajrhss-623	29	34	steroidal	steroidal	ADJ
ajrhss-623	29	35	anti	anti	ADJ
ajrhss-623	29	36	-	-	ADJ
ajrhss-623	29	37	inflammatory	inflammatory	ADJ
ajrhss-623	29	38	drugs	drug	NOUN
ajrhss-623	29	39	(	(	PUNCT
ajrhss-623	29	40	nsaids	nsaid	NOUN
ajrhss-623	29	41	)	)	PUNCT
ajrhss-623	29	42	]	]	PUNCT
ajrhss-623	29	43	,	,	PUNCT
ajrhss-623	29	44	fibrinolysis	fibrinolysis	VERB
ajrhss-623	29	45	inhibitors	inhibitor	NOUN
ajrhss-623	29	46	,	,	PUNCT
ajrhss-623	29	47	drugs	drug	NOUN
ajrhss-623	29	48	that	that	PRON
ajrhss-623	29	49	reduce	reduce	VERB
ajrhss-623	29	50	vascular	vascular	ADJ
ajrhss-623	29	51	fragility	fragility	NOUN
ajrhss-623	29	52	and	and	CCONJ
ajrhss-623	29	53	increase	increase	VERB
ajrhss-623	29	54	the	the	DET
ajrhss-623	29	55	formation	formation	NOUN
ajrhss-623	29	56	of	of	ADP
ajrhss-623	29	57	fibrin	fibrin	NOUN
ajrhss-623	29	58	thrombi	thrombi	NOUN
ajrhss-623	29	59	)	)	PUNCT
ajrhss-623	29	60	,	,	PUNCT
ajrhss-623	29	61	and	and	CCONJ
ajrhss-623	29	62	hormonal	hormonal	ADJ
ajrhss-623	29	63	(	(	PUNCT
ajrhss-623	29	64	progestogens	progestogen	NOUN
ajrhss-623	29	65	,	,	PUNCT
ajrhss-623	29	66	cocs	coc	NOUN
ajrhss-623	29	67	,	,	PUNCT
ajrhss-623	29	68	antigonadotropins	antigonadotropin	NOUN
ajrhss-623	29	69	,	,	PUNCT
ajrhss-623	29	70	agnrh	agnrh	NOUN
ajrhss-623	29	71	)	)	PUNCT
ajrhss-623	30	1	[	[	X
ajrhss-623	30	2	22	22	NUM
ajrhss-623	30	3	]	]	PUNCT
ajrhss-623	30	4	.	.	PUNCT
ajrhss-623	31	1	fibrinolysis	fibrinolysis	NOUN
ajrhss-623	31	2	inhibitors	inhibitor	NOUN
ajrhss-623	31	3	,	,	PUNCT
ajrhss-623	31	4	in	in	ADP
ajrhss-623	31	5	particular	particular	ADJ
ajrhss-623	31	6	tranexamic	tranexamic	ADJ
ajrhss-623	31	7	acid	acid	NOUN
ajrhss-623	31	8	(	(	PUNCT
ajrhss-623	31	9	an	an	DET
ajrhss-623	31	10	inhibitor	inhibitor	NOUN
ajrhss-623	31	11	of	of	ADP
ajrhss-623	31	12	plasminogen	plasminogen	NOUN
ajrhss-623	31	13	activation	activation	NOUN
ajrhss-623	31	14	tranexam	tranexam	NOUN
ajrhss-623	31	15	)	)	PUNCT
ajrhss-623	31	16	,	,	PUNCT
ajrhss-623	31	17	are	be	AUX
ajrhss-623	31	18	considered	consider	VERB
ajrhss-623	31	19	as	as	ADP
ajrhss-623	31	20	non	non	ADJ
ajrhss-623	31	21	-	-	ADJ
ajrhss-623	31	22	hormonal	hormonal	ADJ
ajrhss-623	31	23	drugs	drug	NOUN
ajrhss-623	31	24	of	of	ADP
ajrhss-623	31	25	the	the	DET
ajrhss-623	31	26	1st	1st	ADJ
ajrhss-623	31	27	line	line	NOUN
ajrhss-623	31	28	.	.	PUNCT
ajrhss-623	32	1	treatment	treatment	NOUN
ajrhss-623	32	2	of	of	ADP
ajrhss-623	32	3	uterine	uterine	ADJ
ajrhss-623	32	4	bleeding	bleed	VERB
ajrhss-623	32	5	with	with	ADP
ajrhss-623	32	6	tranexamic	tranexamic	ADJ
ajrhss-623	32	7	acid	acid	NOUN
ajrhss-623	32	8	was	be	AUX
ajrhss-623	32	9	approved	approve	VERB
ajrhss-623	32	10	by	by	ADP
ajrhss-623	32	11	the	the	DET
ajrhss-623	32	12	fda	fda	PROPN
ajrhss-623	32	13	(	(	PUNCT
ajrhss-623	32	14	us	us	PROPN
ajrhss-623	32	15	food	food	NOUN
ajrhss-623	32	16	and	and	CCONJ
ajrhss-623	32	17	drug	drug	NOUN
ajrhss-623	32	18	administration	administration	NOUN
ajrhss-623	32	19	)	)	PUNCT
ajrhss-623	32	20	,	,	PUNCT
ajrhss-623	32	21	in	in	ADP
ajrhss-623	32	22	2006	2006	NUM
ajrhss-623	32	23	.	.	PUNCT
ajrhss-623	33	1	according	accord	VERB
ajrhss-623	33	2	to	to	ADP
ajrhss-623	33	3	the	the	DET
ajrhss-623	33	4	fda	fda	PROPN
ajrhss-623	33	5	recommendations	recommendation	NOUN
ajrhss-623	33	6	,	,	PUNCT
ajrhss-623	33	7	the	the	DET
ajrhss-623	33	8	optimal	optimal	ADJ
ajrhss-623	33	9	daily	daily	ADJ
ajrhss-623	33	10	dose	dose	NOUN
ajrhss-623	33	11	is	be	AUX
ajrhss-623	33	12	4.0	4.0	NUM
ajrhss-623	33	13	g	g	NOUN
ajrhss-623	33	14	,	,	PUNCT
ajrhss-623	33	15	the	the	DET
ajrhss-623	33	16	duration	duration	NOUN
ajrhss-623	33	17	of	of	ADP
ajrhss-623	33	18	administration	administration	NOUN
ajrhss-623	33	19	is	be	AUX
ajrhss-623	33	20	up	up	ADP
ajrhss-623	33	21	to	to	PART
ajrhss-623	33	22	5	5	NUM
ajrhss-623	33	23	days	day	NOUN
ajrhss-623	33	24	.	.	PUNCT
ajrhss-623	34	1	the	the	DET
ajrhss-623	34	2	reduction	reduction	NOUN
ajrhss-623	34	3	in	in	ADP
ajrhss-623	34	4	blood	blood	NOUN
ajrhss-623	34	5	loss	loss	NOUN
ajrhss-623	34	6	is	be	AUX
ajrhss-623	34	7	40–60	40–60	NUM
ajrhss-623	34	8	%	%	NOUN
ajrhss-623	34	9	[	[	X
ajrhss-623	34	10	23	23	NUM
ajrhss-623	34	11	,	,	PUNCT
ajrhss-623	34	12	24	24	NUM
ajrhss-623	34	13	]	]	PUNCT
ajrhss-623	34	14	.	.	PUNCT
ajrhss-623	35	1	a	a	DET
ajrhss-623	35	2	meta	meta	ADJ
ajrhss-623	35	3	-	-	PUNCT
ajrhss-623	35	4	analysis	analysis	NOUN
ajrhss-623	35	5	of	of	ADP
ajrhss-623	35	6	7	7	NUM
ajrhss-623	35	7	randomized	randomized	ADJ
ajrhss-623	35	8	clinical	clinical	ADJ
ajrhss-623	35	9	trials	trial	NOUN
ajrhss-623	35	10	(	(	PUNCT
ajrhss-623	35	11	rcts	rct	NOUN
ajrhss-623	35	12	)	)	PUNCT
ajrhss-623	35	13	found	find	VERB
ajrhss-623	35	14	a	a	DET
ajrhss-623	35	15	decrease	decrease	NOUN
ajrhss-623	35	16	in	in	ADP
ajrhss-623	35	17	menstrual	menstrual	ADJ
ajrhss-623	35	18	blood	blood	NOUN
ajrhss-623	35	19	loss	loss	NOUN
ajrhss-623	35	20	by	by	ADP
ajrhss-623	35	21	93	93	NUM
ajrhss-623	35	22	ml	ml	NOUN
ajrhss-623	35	23	against	against	ADP
ajrhss-623	35	24	the	the	DET
ajrhss-623	35	25	background	background	NOUN
ajrhss-623	35	26	of	of	ADP
ajrhss-623	35	27	tranexamic	tranexamic	ADJ
ajrhss-623	35	28	acid	acid	NOUN
ajrhss-623	35	29	(	(	PUNCT
ajrhss-623	35	30	compared	compare	VERB
ajrhss-623	35	31	with	with	ADP
ajrhss-623	35	32	placebo	placebo	NOUN
ajrhss-623	35	33	)	)	PUNCT
ajrhss-623	35	34	and	and	CCONJ
ajrhss-623	35	35	by	by	ADP
ajrhss-623	35	36	111.0	111.0	NUM
ajrhss-623	35	37	ml	ml	NOUN
ajrhss-623	35	38	(	(	PUNCT
ajrhss-623	35	39	compared	compare	VERB
ajrhss-623	35	40	with	with	ADP
ajrhss-623	35	41	progestogens	progestogen	NOUN
ajrhss-623	35	42	prescribed	prescribe	VERB
ajrhss-623	35	43	in	in	ADP
ajrhss-623	35	44	the	the	DET
ajrhss-623	35	45	second	second	ADJ
ajrhss-623	35	46	phase	phase	NOUN
ajrhss-623	35	47	of	of	ADP
ajrhss-623	35	48	the	the	DET
ajrhss-623	35	49	menstrual	menstrual	ADJ
ajrhss-623	35	50	cycle	cycle	NOUN
ajrhss-623	35	51	)	)	PUNCT
ajrhss-623	36	1	[	[	X
ajrhss-623	36	2	25	25	NUM
ajrhss-623	36	3	]	]	PUNCT
ajrhss-623	36	4	.	.	PUNCT
ajrhss-623	37	1	for	for	ADP
ajrhss-623	37	2	non	non	ADJ
ajrhss-623	37	3	-	-	ADJ
ajrhss-623	37	4	hormonal	hormonal	ADJ
ajrhss-623	37	5	hemostatic	hemostatic	ADJ
ajrhss-623	37	6	therapy	therapy	NOUN
ajrhss-623	37	7	,	,	PUNCT
ajrhss-623	37	8	nsaids	nsaid	NOUN
ajrhss-623	37	9	are	be	AUX
ajrhss-623	37	10	used	use	VERB
ajrhss-623	37	11	(	(	PUNCT
ajrhss-623	37	12	mefenamic	mefenamic	ADJ
ajrhss-623	37	13	,	,	PUNCT
ajrhss-623	37	14	meclofenamic	meclofenamic	ADJ
ajrhss-623	37	15	acid	acid	NOUN
ajrhss-623	37	16	,	,	PUNCT
ajrhss-623	37	17	ibuprofen	ibuprofen	NOUN
ajrhss-623	37	18	,	,	PUNCT
ajrhss-623	37	19	naproxen	naproxen	NOUN
ajrhss-623	37	20	,	,	PUNCT
ajrhss-623	37	21	etc	etc	X
ajrhss-623	37	22	.	.	X
ajrhss-623	37	23	)	)	PUNCT
ajrhss-623	37	24	.	.	PUNCT
ajrhss-623	38	1	the	the	DET
ajrhss-623	38	2	basis	basis	NOUN
ajrhss-623	38	3	for	for	ADP
ajrhss-623	38	4	their	their	PRON
ajrhss-623	38	5	clinical	clinical	ADJ
ajrhss-623	38	6	use	use	NOUN
ajrhss-623	38	7	is	be	AUX
ajrhss-623	38	8	the	the	DET
ajrhss-623	38	9	data	datum	NOUN
ajrhss-623	38	10	on	on	ADP
ajrhss-623	38	11	the	the	DET
ajrhss-623	38	12	relationship	relationship	NOUN
ajrhss-623	38	13	between	between	ADP
ajrhss-623	38	14	elevated	elevated	ADJ
ajrhss-623	38	15	levels	level	NOUN
ajrhss-623	38	16	of	of	ADP
ajrhss-623	38	17	prostaglandins	prostaglandin	NOUN
ajrhss-623	38	18	in	in	ADP
ajrhss-623	38	19	the	the	DET
ajrhss-623	38	20	endometrium	endometrium	NOUN
ajrhss-623	38	21	and	and	CCONJ
ajrhss-623	38	22	excessive	excessive	ADJ
ajrhss-623	38	23	menstrual	menstrual	ADJ
ajrhss-623	38	24	blood	blood	NOUN
ajrhss-623	38	25	loss	loss	NOUN
ajrhss-623	38	26	.	.	PUNCT
ajrhss-623	39	1	according	accord	VERB
ajrhss-623	39	2	to	to	ADP
ajrhss-623	39	3	summary	summary	NOUN
ajrhss-623	39	4	data	datum	NOUN
ajrhss-623	39	5	,	,	PUNCT
ajrhss-623	39	6	blood	blood	NOUN
ajrhss-623	39	7	loss	loss	NOUN
ajrhss-623	39	8	is	be	AUX
ajrhss-623	39	9	reduced	reduce	VERB
ajrhss-623	39	10	by	by	ADP
ajrhss-623	39	11	20–40	20–40	NUM
ajrhss-623	39	12	%	%	NOUN
ajrhss-623	39	13	[	[	X
ajrhss-623	39	14	26	26	NUM
ajrhss-623	39	15	]	]	PUNCT
ajrhss-623	39	16	.	.	PUNCT
ajrhss-623	40	1	according	accord	VERB
ajrhss-623	40	2	to	to	ADP
ajrhss-623	40	3	the	the	DET
ajrhss-623	40	4	international	international	ADJ
ajrhss-623	40	5	recommendations	recommendation	NOUN
ajrhss-623	40	6	of	of	ADP
ajrhss-623	40	7	nice	nice	ADJ
ajrhss-623	40	8	(	(	PUNCT
ajrhss-623	40	9	the	the	DET
ajrhss-623	40	10	national	national	PROPN
ajrhss-623	40	11	institute	institute	PROPN
ajrhss-623	40	12	for	for	ADP
ajrhss-623	40	13	health	health	NOUN
ajrhss-623	40	14	and	and	CCONJ
ajrhss-623	40	15	care	care	PROPN
ajrhss-623	40	16	excellence	excellence	PROPN
ajrhss-623	40	17	)	)	PUNCT
ajrhss-623	40	18	(	(	PUNCT
ajrhss-623	40	19	2007	2007	NUM
ajrhss-623	40	20	)	)	PUNCT
ajrhss-623	40	21	,	,	PUNCT
ajrhss-623	40	22	etamsylate	etamsylate	NOUN
ajrhss-623	40	23	is	be	AUX
ajrhss-623	40	24	ineffective	ineffective	ADJ
ajrhss-623	40	25	in	in	ADP
ajrhss-623	40	26	uterine	uterine	ADJ
ajrhss-623	40	27	bleeding	bleeding	NOUN
ajrhss-623	40	28	(	(	PUNCT
ajrhss-623	40	29	blood	blood	NOUN
ajrhss-623	40	30	loss	loss	NOUN
ajrhss-623	40	31	is	be	AUX
ajrhss-623	40	32	reduced	reduce	VERB
ajrhss-623	40	33	by	by	ADP
ajrhss-623	40	34	0–20	0–20	PROPN
ajrhss-623	40	35	%	%	PROPN
ajrhss-623	40	36	)	)	PUNCT
ajrhss-623	40	37	,	,	PUNCT
ajrhss-623	40	38	and	and	CCONJ
ajrhss-623	40	39	therefore	therefore	ADV
ajrhss-623	40	40	it	it	PRON
ajrhss-623	40	41	is	be	AUX
ajrhss-623	40	42	not	not	PART
ajrhss-623	40	43	recommended	recommend	VERB
ajrhss-623	40	44	for	for	ADP
ajrhss-623	40	45	clinical	clinical	ADJ
ajrhss-623	40	46	use	use	NOUN
ajrhss-623	40	47	[	[	X
ajrhss-623	40	48	3	3	NUM
ajrhss-623	40	49	]	]	PUNCT
ajrhss-623	40	50	.	.	PUNCT
ajrhss-623	41	1	with	with	ADP
ajrhss-623	41	2	aub	aub	PROPN
ajrhss-623	41	3	,	,	PUNCT
ajrhss-623	41	4	cocs	coc	NOUN
ajrhss-623	41	5	are	be	AUX
ajrhss-623	41	6	used	use	VERB
ajrhss-623	41	7	,	,	PUNCT
ajrhss-623	41	8	their	their	PRON
ajrhss-623	41	9	action	action	NOUN
ajrhss-623	41	10	is	be	AUX
ajrhss-623	41	11	mediated	mediate	VERB
ajrhss-623	41	12	by	by	ADP
ajrhss-623	41	13	suppression	suppression	NOUN
ajrhss-623	41	14	of	of	ADP
ajrhss-623	41	15	the	the	DET
ajrhss-623	41	16	secretion	secretion	NOUN
ajrhss-623	41	17	of	of	ADP
ajrhss-623	41	18	gonadotropins	gonadotropin	NOUN
ajrhss-623	41	19	,	,	PUNCT
ajrhss-623	41	20	ovarian	ovarian	ADJ
ajrhss-623	41	21	function	function	NOUN
ajrhss-623	41	22	,	,	PUNCT
ajrhss-623	41	23	and	and	CCONJ
ajrhss-623	41	24	inhibition	inhibition	NOUN
ajrhss-623	41	25	of	of	ADP
ajrhss-623	41	26	the	the	DET
ajrhss-623	41	27	growth	growth	NOUN
ajrhss-623	41	28	of	of	ADP
ajrhss-623	41	29	the	the	DET
ajrhss-623	41	30	glandular	glandular	ADJ
ajrhss-623	41	31	epithelium	epithelium	NOUN
ajrhss-623	41	32	of	of	ADP
ajrhss-623	41	33	the	the	DET
ajrhss-623	41	34	endometrium	endometrium	NOUN
ajrhss-623	41	35	.	.	PUNCT
ajrhss-623	42	1	monophasic	monophasic	ADJ
ajrhss-623	42	2	cocs	coc	NOUN
ajrhss-623	42	3	[	[	X
ajrhss-623	42	4	daily	daily	PROPN
ajrhss-623	42	5	dose	dose	NOUN
ajrhss-623	42	6	of	of	ADP
ajrhss-623	42	7	ethinyl	ethinyl	PROPN
ajrhss-623	42	8	estradiol	estradiol	PROPN
ajrhss-623	42	9	(	(	PUNCT
ajrhss-623	42	10	ee	ee	PROPN
ajrhss-623	42	11	)	)	PUNCT
ajrhss-623	42	12	100	100	NUM
ajrhss-623	42	13	mcg	mcg	NOUN
ajrhss-623	42	14	]	]	PUNCT
ajrhss-623	42	15	are	be	AUX
ajrhss-623	42	16	used	use	VERB
ajrhss-623	42	17	for	for	ADP
ajrhss-623	42	18	hormonal	hormonal	ADJ
ajrhss-623	42	19	hemostasis	hemostasis	NOUN
ajrhss-623	42	20	in	in	ADP
ajrhss-623	42	21	cases	case	NOUN
ajrhss-623	42	22	of	of	ADP
ajrhss-623	42	23	acute	acute	ADJ
ajrhss-623	42	24	aub	aub	NOUN
ajrhss-623	42	25	,	,	PUNCT
ajrhss-623	42	26	as	as	ADV
ajrhss-623	42	27	well	well	ADV
ajrhss-623	42	28	as	as	ADP
ajrhss-623	42	29	for	for	ADP
ajrhss-623	42	30	subsequent	subsequent	ADJ
ajrhss-623	42	31	anti	anti	ADJ
ajrhss-623	42	32	-	-	ADJ
ajrhss-623	42	33	relapse	relapse	ADJ
ajrhss-623	42	34	therapy	therapy	NOUN
ajrhss-623	42	35	according	accord	VERB
ajrhss-623	42	36	to	to	ADP
ajrhss-623	42	37	the	the	DET
ajrhss-623	42	38	contraceptive	contraceptive	ADJ
ajrhss-623	42	39	regimen	regiman	NOUN
ajrhss-623	42	40	.	.	PUNCT
ajrhss-623	43	1	the	the	DET
ajrhss-623	43	2	effectiveness	effectiveness	NOUN
ajrhss-623	43	3	of	of	ADP
ajrhss-623	43	4	cocs	coc	NOUN
ajrhss-623	43	5	in	in	ADP
ajrhss-623	43	6	omc	omc	PROPN
ajrhss-623	43	7	varies	vary	VERB
ajrhss-623	43	8	from	from	ADP
ajrhss-623	43	9	30	30	NUM
ajrhss-623	43	10	to	to	PART
ajrhss-623	43	11	50	50	NUM
ajrhss-623	43	12	%	%	NOUN
ajrhss-623	43	13	[	[	X
ajrhss-623	43	14	21	21	NUM
ajrhss-623	43	15	]	]	PUNCT
ajrhss-623	43	16	.	.	PUNCT
ajrhss-623	44	1	the	the	DET
ajrhss-623	44	2	results	result	NOUN
ajrhss-623	44	3	of	of	ADP
ajrhss-623	44	4	studies	study	NOUN
ajrhss-623	44	5	have	have	AUX
ajrhss-623	44	6	shown	show	VERB
ajrhss-623	44	7	similar	similar	ADJ
ajrhss-623	44	8	efficacy	efficacy	NOUN
ajrhss-623	44	9	in	in	ADP
ajrhss-623	44	10	the	the	DET
ajrhss-623	44	11	form	form	NOUN
ajrhss-623	44	12	of	of	ADP
ajrhss-623	44	13	a	a	DET
ajrhss-623	44	14	50	50	NUM
ajrhss-623	44	15	%	%	NOUN
ajrhss-623	44	16	reduction	reduction	NOUN
ajrhss-623	44	17	in	in	ADP
ajrhss-623	44	18	the	the	DET
ajrhss-623	44	19	volume	volume	NOUN
ajrhss-623	44	20	of	of	ADP
ajrhss-623	44	21	menstrual	menstrual	ADJ
ajrhss-623	44	22	blood	blood	NOUN
ajrhss-623	44	23	loss	loss	NOUN
ajrhss-623	44	24	of	of	ADP
ajrhss-623	44	25	tranexamic	tranexamic	ADJ
ajrhss-623	44	26	acid	acid	NOUN
ajrhss-623	44	27	and	and	CCONJ
ajrhss-623	44	28	coc	coc	PROPN
ajrhss-623	44	29	,	,	PUNCT
ajrhss-623	44	30	which	which	PRON
ajrhss-623	44	31	includes	include	VERB
ajrhss-623	44	32	30	30	NUM
ajrhss-623	44	33	µg	µg	ADV
ajrhss-623	44	34	ee/150	ee/150	NOUN
ajrhss-623	44	35	µg	µg	ADP
ajrhss-623	44	36	levonorgestrel	levonorgestrel	NOUN
ajrhss-623	44	37	(	(	PUNCT
ajrhss-623	44	38	lng	lng	NOUN
ajrhss-623	44	39	)	)	PUNCT
ajrhss-623	44	40	(	(	PUNCT
ajrhss-623	44	41	oralcon	oralcon	NOUN
ajrhss-623	44	42	)	)	PUNCT
ajrhss-623	45	1	[	[	X
ajrhss-623	45	2	27	27	NUM
ajrhss-623	45	3	]	]	PUNCT
ajrhss-623	45	4	.	.	PUNCT
ajrhss-623	46	1	the	the	DET
ajrhss-623	46	2	results	result	NOUN
ajrhss-623	46	3	of	of	ADP
ajrhss-623	46	4	2	2	NUM
ajrhss-623	46	5	multicenter	multicenter	NOUN
ajrhss-623	46	6	placebo	placebo	NOUN
ajrhss-623	46	7	-	-	PUNCT
ajrhss-623	46	8	controlled	control	VERB
ajrhss-623	46	9	studies	study	NOUN
ajrhss-623	46	10	,	,	PUNCT
ajrhss-623	46	11	one	one	NUM
ajrhss-623	46	12	of	of	ADP
ajrhss-623	46	13	which	which	PRON
ajrhss-623	46	14	was	be	AUX
ajrhss-623	46	15	conducted	conduct	VERB
ajrhss-623	46	16	in	in	ADP
ajrhss-623	46	17	north	north	PROPN
ajrhss-623	46	18	america	america	PROPN
ajrhss-623	46	19	,	,	PUNCT
ajrhss-623	46	20	the	the	DET
ajrhss-623	46	21	other	other	ADJ
ajrhss-623	46	22	in	in	ADP
ajrhss-623	46	23	europe	europe	PROPN
ajrhss-623	46	24	and	and	CCONJ
ajrhss-623	46	25	australia	australia	PROPN
ajrhss-623	46	26	,	,	PUNCT
ajrhss-623	46	27	showed	show	VERB
ajrhss-623	46	28	the	the	DET
ajrhss-623	46	29	benefits	benefit	NOUN
ajrhss-623	46	30	of	of	ADP
ajrhss-623	46	31	coc	coc	PROPN
ajrhss-623	46	32	(	(	PUNCT
ajrhss-623	46	33	qlaira	qlaira	PROPN
ajrhss-623	46	34	)	)	PUNCT
ajrhss-623	46	35	,	,	PUNCT
ajrhss-623	46	36	which	which	PRON
ajrhss-623	46	37	includes	include	VERB
ajrhss-623	46	38	natural	natural	ADJ
ajrhss-623	46	39	estrogen	estrogen	NOUN
ajrhss-623	46	40	estradiol	estradiol	PROPN
ajrhss-623	46	41	valerate	valerate	PROPN
ajrhss-623	46	42	(	(	PUNCT
ajrhss-623	46	43	ev	ev	PROPN
ajrhss-623	46	44	)	)	PUNCT
ajrhss-623	46	45	and	and	CCONJ
ajrhss-623	46	46	a	a	DET
ajrhss-623	46	47	hybrid	hybrid	ADJ
ajrhss-623	46	48	progestogen	progestogen	NOUN
ajrhss-623	46	49	dienogest	dienog	ADJ
ajrhss-623	46	50	(	(	PUNCT
ajrhss-623	46	51	dng	dng	PROPN
ajrhss-623	46	52	)	)	PUNCT
ajrhss-623	46	53	.	.	PUNCT
ajrhss-623	47	1	a	a	DET
ajrhss-623	47	2	3	3	NUM
ajrhss-623	47	3	-	-	PUNCT
ajrhss-623	47	4	month	month	NOUN
ajrhss-623	47	5	intake	intake	NOUN
ajrhss-623	47	6	of	of	ADP
ajrhss-623	47	7	the	the	DET
ajrhss-623	47	8	drug	drug	NOUN
ajrhss-623	47	9	led	lead	VERB
ajrhss-623	47	10	to	to	ADP
ajrhss-623	47	11	a	a	DET
ajrhss-623	47	12	decrease	decrease	NOUN
ajrhss-623	47	13	in	in	ADP
ajrhss-623	47	14	the	the	DET
ajrhss-623	47	15	volume	volume	NOUN
ajrhss-623	47	16	of	of	ADP
ajrhss-623	47	17	menstrual	menstrual	ADJ
ajrhss-623	47	18	blood	blood	NOUN
ajrhss-623	47	19	loss	loss	NOUN
ajrhss-623	47	20	by	by	ADP
ajrhss-623	47	21	71–79	71–79	NUM
ajrhss-623	47	22	%	%	NOUN
ajrhss-623	47	23	,	,	PUNCT
ajrhss-623	47	24	a	a	DET
ajrhss-623	47	25	6	6	NUM
ajrhss-623	47	26	-	-	PUNCT
ajrhss-623	47	27	month	month	NOUN
ajrhss-623	47	28	intake	intake	NOUN
ajrhss-623	47	29	by	by	ADP
ajrhss-623	47	30	a	a	DET
ajrhss-623	47	31	total	total	NOUN
ajrhss-623	47	32	of	of	ADP
ajrhss-623	47	33	88	88	NUM
ajrhss-623	47	34	%	%	NOUN
ajrhss-623	47	35	,	,	PUNCT
ajrhss-623	47	36	in	in	ADP
ajrhss-623	47	37	64	64	NUM
ajrhss-623	47	38	%	%	NOUN
ajrhss-623	47	39	of	of	ADP
ajrhss-623	47	40	patients	patient	NOUN
ajrhss-623	47	41	,	,	PUNCT
ajrhss-623	47	42	normalization	normalization	NOUN
ajrhss-623	47	43	of	of	ADP
ajrhss-623	47	44	the	the	DET
ajrhss-623	47	45	menstrual	menstrual	ADJ
ajrhss-623	47	46	cycle	cycle	NOUN
ajrhss-623	47	47	parameters	parameter	NOUN
ajrhss-623	47	48	was	be	AUX
ajrhss-623	47	49	observed	observe	VERB
ajrhss-623	47	50	[	[	X
ajrhss-623	47	51	28	28	NUM
ajrhss-623	47	52	,	,	PUNCT
ajrhss-623	47	53	29	29	NUM
ajrhss-623	47	54	]	]	PUNCT
ajrhss-623	47	55	.	.	PUNCT
ajrhss-623	48	1	the	the	DET
ajrhss-623	48	2	high	high	ADJ
ajrhss-623	48	3	efficiency	efficiency	NOUN
ajrhss-623	48	4	of	of	ADP
ajrhss-623	48	5	this	this	DET
ajrhss-623	48	6	type	type	NOUN
ajrhss-623	48	7	of	of	ADP
ajrhss-623	48	8	therapy	therapy	NOUN
ajrhss-623	48	9	is	be	AUX
ajrhss-623	48	10	associated	associate	VERB
ajrhss-623	48	11	with	with	ADP
ajrhss-623	48	12	early	early	ADJ
ajrhss-623	48	13	proliferation	proliferation	NOUN
ajrhss-623	48	14	of	of	ADP
ajrhss-623	48	15	the	the	DET
ajrhss-623	48	16	endometrium	endometrium	NOUN
ajrhss-623	48	17	under	under	ADP
ajrhss-623	48	18	the	the	DET
ajrhss-623	48	19	influence	influence	NOUN
ajrhss-623	48	20	of	of	ADP
ajrhss-623	48	21	estrogens	estrogen	NOUN
ajrhss-623	48	22	,	,	PUNCT
ajrhss-623	48	23	an	an	DET
ajrhss-623	48	24	increase	increase	NOUN
ajrhss-623	48	25	in	in	ADP
ajrhss-623	48	26	the	the	DET
ajrhss-623	48	27	expression	expression	NOUN
ajrhss-623	48	28	of	of	ADP
ajrhss-623	48	29	progesterone	progesterone	NOUN
ajrhss-623	48	30	receptors	receptor	NOUN
ajrhss-623	48	31	,	,	PUNCT
ajrhss-623	48	32	and	and	CCONJ
ajrhss-623	48	33	the	the	DET
ajrhss-623	48	34	antiproliferative	antiproliferative	ADJ
ajrhss-623	48	35	effect	effect	NOUN
ajrhss-623	48	36	of	of	ADP
ajrhss-623	48	37	high	high	ADJ
ajrhss-623	48	38	doses	dose	NOUN
ajrhss-623	48	39	of	of	ADP
ajrhss-623	48	40	dienogest	dienog	ADJ
ajrhss-623	48	41	.	.	PUNCT
ajrhss-623	49	1	along	along	ADP
ajrhss-623	49	2	with	with	ADP
ajrhss-623	49	3	cocs	coc	NOUN
ajrhss-623	49	4	for	for	ADP
ajrhss-623	49	5	the	the	DET
ajrhss-623	49	6	treatment	treatment	NOUN
ajrhss-623	49	7	of	of	ADP
ajrhss-623	49	8	aub	aub	NOUN
ajrhss-623	49	9	,	,	PUNCT
ajrhss-623	49	10	progestogens	progestogen	NOUN
ajrhss-623	49	11	are	be	AUX
ajrhss-623	49	12	used	use	VERB
ajrhss-623	49	13	in	in	ADP
ajrhss-623	49	14	cyclic	cyclic	ADJ
ajrhss-623	49	15	and	and	CCONJ
ajrhss-623	49	16	continuous	continuous	ADJ
ajrhss-623	49	17	modes	mode	NOUN
ajrhss-623	49	18	.	.	PUNCT
ajrhss-623	50	1	the	the	DET
ajrhss-623	50	2	results	result	NOUN
ajrhss-623	50	3	of	of	ADP
ajrhss-623	50	4	one	one	NUM
ajrhss-623	50	5	of	of	ADP
ajrhss-623	50	6	the	the	DET
ajrhss-623	50	7	meta	meta	ADJ
ajrhss-623	50	8	-	-	PUNCT
ajrhss-623	50	9	analyzes	analyze	NOUN
ajrhss-623	50	10	indicate	indicate	VERB
ajrhss-623	50	11	the	the	DET
ajrhss-623	50	12	low	low	ADJ
ajrhss-623	50	13	effectiveness	effectiveness	NOUN
ajrhss-623	50	14	of	of	ADP
ajrhss-623	50	15	progestogens	progestogen	NOUN
ajrhss-623	50	16	prescribed	prescribe	VERB
ajrhss-623	50	17	in	in	ADP
ajrhss-623	50	18	american	american	PROPN
ajrhss-623	50	19	journal	journal	PROPN
ajrhss-623	50	20	of	of	ADP
ajrhss-623	50	21	research	research	NOUN
ajrhss-623	50	22	in	in	ADP
ajrhss-623	50	23	humanities	humanity	NOUN
ajrhss-623	50	24	and	and	CCONJ
ajrhss-623	50	25	social	social	ADJ
ajrhss-623	50	26	sciences	science	NOUN
ajrhss-623	50	27	volume	volume	NOUN
ajrhss-623	50	28	11	11	NUM
ajrhss-623	50	29	,	,	PUNCT
ajrhss-623	50	30	april	april	PROPN
ajrhss-623	50	31	,	,	PUNCT
ajrhss-623	50	32	2023	2023	NUM
ajrhss-623	50	33	p	p	NOUN
ajrhss-623	50	34	a	a	DET
ajrhss-623	50	35	g	g	NOUN
ajrhss-623	50	36	e	e	NOUN
ajrhss-623	50	37	|	|	ADV
ajrhss-623	50	38	69	69	NUM
ajrhss-623	50	39	www.americanjournal.org	www.americanjournal.org	NOUN
ajrhss-623	50	40	the	the	DET
ajrhss-623	50	41	luteal	luteal	ADJ
ajrhss-623	50	42	phase	phase	NOUN
ajrhss-623	50	43	of	of	ADP
ajrhss-623	50	44	the	the	DET
ajrhss-623	50	45	cycle	cycle	NOUN
ajrhss-623	50	46	in	in	ADP
ajrhss-623	50	47	the	the	DET
ajrhss-623	50	48	treatment	treatment	NOUN
ajrhss-623	50	49	of	of	ADP
ajrhss-623	50	50	uterine	uterine	ADJ
ajrhss-623	50	51	bleeding	bleeding	NOUN
ajrhss-623	50	52	compared	compare	VERB
ajrhss-623	50	53	with	with	ADP
ajrhss-623	50	54	nsaids	nsaid	NOUN
ajrhss-623	50	55	,	,	PUNCT
ajrhss-623	50	56	tranexamic	tranexamic	ADJ
ajrhss-623	50	57	acid	acid	NOUN
ajrhss-623	50	58	or	or	CCONJ
ajrhss-623	50	59	danazol	danazol	ADJ
ajrhss-623	50	60	[	[	X
ajrhss-623	50	61	31	31	NUM
ajrhss-623	50	62	]	]	PUNCT
ajrhss-623	50	63	.	.	PUNCT
ajrhss-623	51	1	the	the	DET
ajrhss-623	51	2	most	most	ADV
ajrhss-623	51	3	effective	effective	ADJ
ajrhss-623	51	4	is	be	AUX
ajrhss-623	51	5	the	the	DET
ajrhss-623	51	6	use	use	NOUN
ajrhss-623	51	7	of	of	ADP
ajrhss-623	51	8	progestogens	progestogen	NOUN
ajrhss-623	51	9	in	in	ADP
ajrhss-623	51	10	a	a	DET
ajrhss-623	51	11	continuous	continuous	ADJ
ajrhss-623	51	12	regimen	regimen	NOUN
ajrhss-623	51	13	systemically	systemically	ADV
ajrhss-623	51	14	or	or	CCONJ
ajrhss-623	51	15	in	in	ADP
ajrhss-623	51	16	the	the	DET
ajrhss-623	51	17	form	form	NOUN
ajrhss-623	51	18	of	of	ADP
ajrhss-623	51	19	an	an	DET
ajrhss-623	51	20	intrauterine	intrauterine	ADJ
ajrhss-623	51	21	system	system	NOUN
ajrhss-623	51	22	that	that	PRON
ajrhss-623	51	23	releases	release	VERB
ajrhss-623	51	24	levonorgestrel	levonorgestrel	NOUN
ajrhss-623	51	25	(	(	PUNCT
ajrhss-623	51	26	lng	lng	NOUN
ajrhss-623	51	27	-	-	PUNCT
ajrhss-623	51	28	iud	iud	NOUN
ajrhss-623	51	29	)	)	PUNCT
ajrhss-623	51	30	.	.	PUNCT
ajrhss-623	52	1	according	accord	VERB
ajrhss-623	52	2	to	to	ADP
ajrhss-623	52	3	the	the	DET
ajrhss-623	52	4	results	result	NOUN
ajrhss-623	52	5	of	of	ADP
ajrhss-623	52	6	a	a	DET
ajrhss-623	52	7	metaanalysis	metaanalysis	NOUN
ajrhss-623	52	8	,	,	PUNCT
ajrhss-623	52	9	the	the	DET
ajrhss-623	52	10	reduction	reduction	NOUN
ajrhss-623	52	11	in	in	ADP
ajrhss-623	52	12	menstrual	menstrual	ADJ
ajrhss-623	52	13	blood	blood	NOUN
ajrhss-623	52	14	loss	loss	NOUN
ajrhss-623	52	15	,	,	PUNCT
ajrhss-623	52	16	estimated	estimate	VERB
ajrhss-623	52	17	by	by	ADP
ajrhss-623	52	18	the	the	DET
ajrhss-623	52	19	alkalinohematin	alkalinohematin	NOUN
ajrhss-623	52	20	method	method	NOUN
ajrhss-623	52	21	,	,	PUNCT
ajrhss-623	52	22	was	be	AUX
ajrhss-623	52	23	77–89	77–89	NUM
ajrhss-623	52	24	%	%	NOUN
ajrhss-623	52	25	after	after	ADP
ajrhss-623	52	26	3	3	NUM
ajrhss-623	52	27	months	month	NOUN
ajrhss-623	52	28	of	of	ADP
ajrhss-623	52	29	exposure	exposure	NOUN
ajrhss-623	52	30	to	to	ADP
ajrhss-623	52	31	the	the	DET
ajrhss-623	52	32	lng	lng	PROPN
ajrhss-623	52	33	-	-	PUNCT
ajrhss-623	52	34	iud	iud	PROPN
ajrhss-623	52	35	,	,	PUNCT
ajrhss-623	52	36	and	and	CCONJ
ajrhss-623	52	37	97	97	NUM
ajrhss-623	52	38	%	%	NOUN
ajrhss-623	52	39	after	after	ADP
ajrhss-623	52	40	6	6	NUM
ajrhss-623	52	41	months	month	NOUN
ajrhss-623	52	42	[	[	X
ajrhss-623	52	43	32	32	NUM
ajrhss-623	52	44	]	]	PUNCT
ajrhss-623	52	45	.	.	PUNCT
ajrhss-623	53	1	conclusion	conclusion	NOUN
ajrhss-623	53	2	the	the	DET
ajrhss-623	53	3	results	result	NOUN
ajrhss-623	53	4	of	of	ADP
ajrhss-623	53	5	systematic	systematic	ADJ
ajrhss-623	53	6	reviews	review	NOUN
ajrhss-623	53	7	and	and	CCONJ
ajrhss-623	53	8	meta	meta	NOUN
ajrhss-623	53	9	-	-	PUNCT
ajrhss-623	53	10	analyses	analysis	NOUN
ajrhss-623	53	11	formed	form	VERB
ajrhss-623	53	12	the	the	DET
ajrhss-623	53	13	basis	basis	NOUN
ajrhss-623	53	14	of	of	ADP
ajrhss-623	53	15	the	the	DET
ajrhss-623	53	16	clinical	clinical	ADJ
ajrhss-623	53	17	recommendations	recommendation	NOUN
ajrhss-623	53	18	of	of	ADP
ajrhss-623	53	19	the	the	DET
ajrhss-623	53	20	national	national	PROPN
ajrhss-623	53	21	institutes	institutes	PROPN
ajrhss-623	53	22	of	of	ADP
ajrhss-623	53	23	health	health	PROPN
ajrhss-623	53	24	(	(	PUNCT
ajrhss-623	53	25	nice	nice	ADJ
ajrhss-623	53	26	)	)	PUNCT
ajrhss-623	53	27	,	,	PUNCT
ajrhss-623	53	28	the	the	DET
ajrhss-623	53	29	american	american	ADJ
ajrhss-623	53	30	and	and	CCONJ
ajrhss-623	53	31	canadian	canadian	ADJ
ajrhss-623	53	32	associations	association	NOUN
ajrhss-623	53	33	of	of	ADP
ajrhss-623	53	34	obstetricians	obstetrician	NOUN
ajrhss-623	53	35	and	and	CCONJ
ajrhss-623	53	36	gynecologists	gynecologist	NOUN
ajrhss-623	53	37	(	(	PUNCT
ajrhss-623	53	38	2013	2013	NUM
ajrhss-623	53	39	)	)	PUNCT
ajrhss-623	54	1	[	[	X
ajrhss-623	54	2	3	3	NUM
ajrhss-623	54	3	,	,	PUNCT
ajrhss-623	54	4	21	21	NUM
ajrhss-623	54	5	]	]	PUNCT
ajrhss-623	54	6	for	for	ADP
ajrhss-623	54	7	drug	drug	NOUN
ajrhss-623	54	8	and	and	CCONJ
ajrhss-623	54	9	non	non	ADJ
ajrhss-623	54	10	-	-	ADJ
ajrhss-623	54	11	drug	drug	ADJ
ajrhss-623	54	12	therapy	therapy	NOUN
ajrhss-623	54	13	of	of	ADP
ajrhss-623	54	14	uterine	uterine	ADJ
ajrhss-623	54	15	bleeding	bleeding	NOUN
ajrhss-623	54	16	.	.	PUNCT
ajrhss-623	55	1	with	with	ADP
ajrhss-623	55	2	evidence	evidence	NOUN
ajrhss-623	55	3	level	level	NOUN
ajrhss-623	55	4	a	a	PRON
ajrhss-623	55	5	,	,	PUNCT
ajrhss-623	55	6	lng	lng	PROPN
ajrhss-623	55	7	-	-	PUNCT
ajrhss-623	55	8	iud	iud	PROPN
ajrhss-623	55	9	,	,	PUNCT
ajrhss-623	55	10	long	long	ADV
ajrhss-623	55	11	-	-	PUNCT
ajrhss-623	55	12	acting	act	VERB
ajrhss-623	55	13	progestogens	progestogen	NOUN
ajrhss-623	55	14	,	,	PUNCT
ajrhss-623	55	15	tranexam	tranexam	NOUN
ajrhss-623	55	16	,	,	PUNCT
ajrhss-623	55	17	nsaids	nsaid	NOUN
ajrhss-623	55	18	,	,	PUNCT
ajrhss-623	55	19	cocs	coc	NOUN
ajrhss-623	55	20	are	be	AUX
ajrhss-623	55	21	recommended	recommend	VERB
ajrhss-623	55	22	as	as	ADP
ajrhss-623	55	23	firstline	firstline	ADJ
ajrhss-623	55	24	drugs	drug	NOUN
ajrhss-623	55	25	.	.	PUNCT
ajrhss-623	56	1	danazol	danazol	ADJ
ajrhss-623	56	2	,	,	PUNCT
ajrhss-623	56	3	short	short	ADJ
ajrhss-623	56	4	progestogen	progestogen	NOUN
ajrhss-623	56	5	regimen	regiman	NOUN
ajrhss-623	56	6	,	,	PUNCT
ajrhss-623	56	7	etamsylate	etamsylate	NOUN
ajrhss-623	56	8	is	be	AUX
ajrhss-623	56	9	not	not	PART
ajrhss-623	56	10	recommended	recommend	VERB
ajrhss-623	56	11	for	for	SCONJ
ajrhss-623	56	12	i	i	PRON
ajrhss-623	56	13	treat	treat	VERB
ajrhss-623	56	14	uterine	uterine	ADJ
ajrhss-623	56	15	bleeding	bleeding	NOUN
ajrhss-623	56	16	.	.	PUNCT
ajrhss-623	57	1	references	reference	NOUN
ajrhss-623	57	2	1	1	NUM
ajrhss-623	57	3	.	.	PUNCT
ajrhss-623	58	1	dumanovskaya	dumanovskaya	PROPN
ajrhss-623	58	2	m.r	m.r	PROPN
ajrhss-623	58	3	.	.	PROPN
ajrhss-623	58	4	,	,	PUNCT
ajrhss-623	58	5	chernukha	chernukha	NOUN
ajrhss-623	58	6	g.e	g.e	PROPN
ajrhss-623	58	7	.	.	PROPN
ajrhss-623	58	8	,	,	PUNCT
ajrhss-623	58	9	tabeeva	tabeeva	PROPN
ajrhss-623	58	10	g.i	g.i	PROPN
ajrhss-623	58	11	.	.	PROPN
ajrhss-623	58	12	,	,	PUNCT
ajrhss-623	58	13	asaturova	asaturova	PROPN
ajrhss-623	58	14	a.v	a.v	PROPN
ajrhss-623	58	15	.	.	PROPN
ajrhss-623	58	16	endometrial	endometrial	ADJ
ajrhss-623	58	17	hyperplasia	hyperplasia	NOUN
ajrhss-623	58	18	:	:	PUNCT
ajrhss-623	58	19	the	the	DET
ajrhss-623	58	20	search	search	NOUN
ajrhss-623	58	21	for	for	ADP
ajrhss-623	58	22	optimal	optimal	ADJ
ajrhss-623	58	23	solutions	solution	NOUN
ajrhss-623	58	24	and	and	CCONJ
ajrhss-623	58	25	strategies	strategy	NOUN
ajrhss-623	58	26	.	.	PUNCT
ajrhss-623	59	1	obstetrics	obstetric	NOUN
ajrhss-623	59	2	and	and	CCONJ
ajrhss-623	59	3	gynecology	gynecology	NOUN
ajrhss-623	59	4	.	.	PUNCT
ajrhss-623	60	1	2021;4:23	2021;4:23	ADJ
ajrhss-623	60	2	-	-	SYM
ajrhss-623	60	3	31	31	NUM
ajrhss-623	60	4	2	2	NUM
ajrhss-623	60	5	.	.	PUNCT
ajrhss-623	60	6	chernukha	chernukha	PROPN
ajrhss-623	60	7	g.e	g.e	PROPN
ajrhss-623	60	8	.	.	PROPN
ajrhss-623	60	9	,	,	PUNCT
ajrhss-623	60	10	asaturova	asaturova	PROPN
ajrhss-623	60	11	a.v	a.v	PROPN
ajrhss-623	61	1	.	.	PROPN
ajrhss-623	61	2	,	,	PUNCT
ajrhss-623	61	3	ivanov	ivanov	PROPN
ajrhss-623	61	4	i.a	i.a	PROPN
ajrhss-623	61	5	.	.	PROPN
ajrhss-623	61	6	,	,	PUNCT
ajrhss-623	61	7	dumanovskaya	dumanovskaya	PROPN
ajrhss-623	61	8	m.r	m.r	PROPN
ajrhss-623	61	9	.	.	PUNCT
ajrhss-623	62	1	the	the	DET
ajrhss-623	62	2	structure	structure	NOUN
ajrhss-623	62	3	of	of	ADP
ajrhss-623	62	4	endometrial	endometrial	ADJ
ajrhss-623	62	5	pathology	pathology	NOUN
ajrhss-623	62	6	in	in	ADP
ajrhss-623	62	7	different	different	ADJ
ajrhss-623	62	8	age	age	NOUN
ajrhss-623	62	9	periods	period	NOUN
ajrhss-623	62	10	.	.	PUNCT
ajrhss-623	63	1	obstetrics	obstetric	NOUN
ajrhss-623	63	2	and	and	CCONJ
ajrhss-623	63	3	gynecology	gynecology	NOUN
ajrhss-623	63	4	.	.	PUNCT
ajrhss-623	64	1	2018;8:129	2018;8:129	NUM
ajrhss-623	64	2	-	-	SYM
ajrhss-623	64	3	35	35	NUM
ajrhss-623	64	4	.	.	PUNCT
ajrhss-623	65	1	3	3	X
ajrhss-623	65	2	.	.	X
ajrhss-623	65	3	kazachkova	kazachkova	PROPN
ajrhss-623	66	1	e.a	e.a	PROPN
ajrhss-623	66	2	.	.	PROPN
ajrhss-623	66	3	,	,	PUNCT
ajrhss-623	66	4	zatvornitskaya	zatvornitskaya	PROPN
ajrhss-623	66	5	a.v	a.v	PROPN
ajrhss-623	66	6	.	.	PROPN
ajrhss-623	66	7	,	,	PUNCT
ajrhss-623	66	8	voropaeva	voropaeva	PROPN
ajrhss-623	66	9	e.e	e.e	PROPN
ajrhss-623	66	10	.	.	PROPN
ajrhss-623	66	11	,	,	PUNCT
ajrhss-623	66	12	kazachkov	kazachkov	PROPN
ajrhss-623	66	13	e.l	e.l	PROPN
ajrhss-623	66	14	.	.	PROPN
ajrhss-623	66	15	endometrial	endometrial	ADJ
ajrhss-623	66	16	hyperplasia	hyperplasia	NOUN
ajrhss-623	66	17	associated	associate	VERB
ajrhss-623	66	18	with	with	ADP
ajrhss-623	66	19	chronic	chronic	ADJ
ajrhss-623	66	20	endometritis	endometritis	NOUN
ajrhss-623	66	21	:	:	PUNCT
ajrhss-623	66	22	clinical	clinical	ADJ
ajrhss-623	66	23	and	and	CCONJ
ajrhss-623	66	24	morphological	morphological	ADJ
ajrhss-623	66	25	features	feature	NOUN
ajrhss-623	66	26	.	.	PUNCT
ajrhss-623	67	1	ural	ural	ADJ
ajrhss-623	67	2	medical	medical	ADJ
ajrhss-623	67	3	journal	journal	NOUN
ajrhss-623	67	4	.	.	PUNCT
ajrhss-623	68	1	2020;3(186):36	2020;3(186):36	NUM
ajrhss-623	68	2	-	-	SYM
ajrhss-623	68	3	41	41	NUM
ajrhss-623	68	4	4	4	NUM
ajrhss-623	68	5	.	.	PUNCT
ajrhss-623	69	1	capmas	capma	VERB
ajrhss-623	69	2	p	p	SYM
ajrhss-623	69	3	,	,	PUNCT
ajrhss-623	69	4	pourcelot	pourcelot	NOUN
ajrhss-623	69	5	ag	ag	PROPN
ajrhss-623	69	6	,	,	PUNCT
ajrhss-623	69	7	giral	giral	ADJ
ajrhss-623	69	8	e	e	NOUN
ajrhss-623	69	9	,	,	PUNCT
ajrhss-623	69	10	et	et	PROPN
ajrhss-623	69	11	al	al	PROPN
ajrhss-623	69	12	.	.	PUNCT
ajrhss-623	70	1	office	office	NOUN
ajrhss-623	70	2	hysteroscopy	hysteroscopy	NOUN
ajrhss-623	70	3	:	:	PUNCT
ajrhss-623	70	4	a	a	DET
ajrhss-623	70	5	report	report	NOUN
ajrhss-623	70	6	of	of	ADP
ajrhss-623	70	7	2402	2402	NUM
ajrhss-623	70	8	cases	case	NOUN
ajrhss-623	70	9	.	.	PUNCT
ajrhss-623	71	1	j	j	PROPN
ajrhss-623	71	2	gynecol	gynecol	PROPN
ajrhss-623	71	3	obstet	obstet	PROPN
ajrhss-623	71	4	biol	biol	PROPN
ajrhss-623	71	5	reprod	reprod	PROPN
ajrhss-623	71	6	(	(	PUNCT
ajrhss-623	71	7	paris	paris	PROPN
ajrhss-623	71	8	)	)	PUNCT
ajrhss-623	71	9	.	.	PUNCT
ajrhss-623	72	1	2016;45(5):445	2016;45(5):445	NUM
ajrhss-623	72	2	-	-	PUNCT
ajrhss-623	72	3	50	50	NUM
ajrhss-623	72	4	.	.	PUNCT
ajrhss-623	72	5	5	5	X
ajrhss-623	72	6	.	.	X
ajrhss-623	72	7	munro	munro	PROPN
ajrhss-623	72	8	mg	mg	PROPN
ajrhss-623	72	9	,	,	PUNCT
ajrhss-623	72	10	critchley	critchley	PROPN
ajrhss-623	72	11	ho	ho	PROPN
ajrhss-623	72	12	,	,	PUNCT
ajrhss-623	72	13	fraser	fraser	PROPN
ajrhss-623	72	14	is	be	AUX
ajrhss-623	72	15	.	.	PUNCT
ajrhss-623	73	1	the	the	DET
ajrhss-623	73	2	two	two	NUM
ajrhss-623	73	3	figo	figo	ADJ
ajrhss-623	73	4	systems	system	NOUN
ajrhss-623	73	5	for	for	ADP
ajrhss-623	73	6	normal	normal	ADJ
ajrhss-623	73	7	and	and	CCONJ
ajrhss-623	73	8	abnormal	abnormal	ADJ
ajrhss-623	73	9	uterine	uterine	ADJ
ajrhss-623	73	10	bleeding	bleed	VERB
ajrhss-623	73	11	symptoms	symptom	NOUN
ajrhss-623	73	12	and	and	CCONJ
ajrhss-623	73	13	classification	classification	NOUN
ajrhss-623	73	14	of	of	ADP
ajrhss-623	73	15	causes	cause	NOUN
ajrhss-623	73	16	of	of	ADP
ajrhss-623	73	17	abnormal	abnormal	ADJ
ajrhss-623	73	18	uterine	uterine	ADJ
ajrhss-623	73	19	bleeding	bleeding	NOUN
ajrhss-623	73	20	in	in	ADP
ajrhss-623	73	21	the	the	DET
ajrhss-623	73	22	reproductive	reproductive	ADJ
ajrhss-623	73	23	years	year	NOUN
ajrhss-623	73	24	:	:	PUNCT
ajrhss-623	73	25	2018	2018	NUM
ajrhss-623	73	26	revisions	revision	NOUN
ajrhss-623	73	27	.	.	PUNCT
ajrhss-623	74	1	int	int	NOUN
ajrhss-623	74	2	j	j	PROPN
ajrhss-623	74	3	gynecol	gynecol	PROPN
ajrhss-623	74	4	obstet	obstet	NOUN
ajrhss-623	74	5	.	.	PUNCT
ajrhss-623	75	1	2018;143(3):393	2018;143(3):393	NUM
ajrhss-623	75	2	-	-	SYM
ajrhss-623	75	3	408	408	NUM
ajrhss-623	75	4	.	.	PUNCT
ajrhss-623	76	1	doi:10.1002	doi:10.1002	NOUN
ajrhss-623	76	2	/	/	SYM
ajrhss-623	76	3	ijgo.12666	ijgo.12666	PROPN
ajrhss-623	76	4	6	6	NUM
ajrhss-623	76	5	.	.	PUNCT
ajrhss-623	76	6	soner	soner	NOUN
ajrhss-623	76	7	gök	gök	PROPN
ajrhss-623	76	8	,	,	PUNCT
ajrhss-623	76	9	erkan	erkan	PROPN
ajrhss-623	76	10	alataş	alataş	PROPN
ajrhss-623	76	11	,	,	PUNCT
ajrhss-623	76	12	effects	effect	NOUN
ajrhss-623	76	13	of	of	ADP
ajrhss-623	76	14	levonorgestrel	levonorgestrel	NOUN
ajrhss-623	76	15	-	-	PUNCT
ajrhss-623	76	16	releasing	release	VERB
ajrhss-623	76	17	intrauterine	intrauterine	ADJ
ajrhss-623	76	18	device	device	NOUN
ajrhss-623	76	19	therapy	therapy	NOUN
ajrhss-623	76	20	on	on	ADP
ajrhss-623	76	21	ovarian	ovarian	ADJ
ajrhss-623	76	22	reserve	reserve	NOUN
ajrhss-623	76	23	in	in	ADP
ajrhss-623	76	24	menorrhagia	menorrhagia	NOUN
ajrhss-623	76	25	,	,	PUNCT
ajrhss-623	76	26	cureus	cureus	NOUN
ajrhss-623	76	27	,	,	PUNCT
ajrhss-623	76	28	10.7759	10.7759	NUM
ajrhss-623	76	29	/	/	SYM
ajrhss-623	76	30	cureus.31721	cureus.31721	PROPN
ajrhss-623	76	31	,	,	PUNCT
ajrhss-623	76	32	(	(	PUNCT
ajrhss-623	76	33	2022	2022	NUM
ajrhss-623	76	34	)	)	PUNCT
ajrhss-623	76	35	.	.	PUNCT
ajrhss-623	77	1	7.katarzyna	7.katarzyna	NUM
ajrhss-623	77	2	jobda	jobda	NOUN
ajrhss-623	77	3	,	,	PUNCT
ajrhss-623	77	4	łukasz	łukasz	PROPN
ajrhss-623	77	5	szeszko	szeszko	PROPN
ajrhss-623	77	6	,	,	PUNCT
ajrhss-623	77	7	grzegorz	grzegorz	NOUN
ajrhss-623	77	8	wróbel	wróbel	PROPN
ajrhss-623	77	9	,	,	PUNCT
ajrhss-623	77	10	marta	marta	PROPN
ajrhss-623	77	11	głuchowska	głuchowska	PROPN
ajrhss-623	77	12	,	,	PUNCT
ajrhss-623	77	13	joanna	joanna	PROPN
ajrhss-623	77	14	krupińska	krupińska	PROPN
ajrhss-623	77	15	,	,	PUNCT
ajrhss-623	77	16	artur	artur	PROPN
ajrhss-623	77	17	szeszko	szeszko	PROPN
ajrhss-623	77	18	,	,	PUNCT
ajrhss-623	77	19	beata	beata	VERB
ajrhss-623	77	20	makaruk	makaruk	NOUN
ajrhss-623	77	21	,	,	PUNCT
ajrhss-623	77	22	przemysław	przemysław	ADJ
ajrhss-623	77	23	oszukowski	oszukowski	NOUN
ajrhss-623	77	24	,	,	PUNCT
ajrhss-623	77	25	paweł	paweł	VERB
ajrhss-623	77	26	zieliński	zieliński	NOUN
ajrhss-623	77	27	,	,	PUNCT
ajrhss-623	77	28	hemoglobin	hemoglobin	NOUN
ajrhss-623	77	29	levels	level	NOUN
ajrhss-623	77	30	and	and	CCONJ
ajrhss-623	77	31	platelet	platelet	NOUN
ajrhss-623	77	32	counts	count	NOUN
ajrhss-623	77	33	after	after	ADP
ajrhss-623	77	34	hysteroscopy	hysteroscopy	NOUN
ajrhss-623	77	35	due	due	ADP
ajrhss-623	77	36	to	to	ADP
ajrhss-623	77	37	abnormal	abnormal	ADJ
ajrhss-623	77	38	uterine	uterine	ADJ
ajrhss-623	77	39	bleeding	bleeding	NOUN
ajrhss-623	77	40	,	,	PUNCT
ajrhss-623	77	41	diagnostics	diagnostic	NOUN
ajrhss-623	77	42	,	,	PUNCT
ajrhss-623	77	43	10.3390	10.3390	NUM
ajrhss-623	77	44	/	/	SYM
ajrhss-623	77	45	diagnostics12030594	diagnostics12030594	PROPN
ajrhss-623	77	46	,	,	PUNCT
ajrhss-623	77	47	12	12	NUM
ajrhss-623	77	48	,	,	PUNCT
ajrhss-623	77	49	3	3	NUM
ajrhss-623	77	50	,	,	PUNCT
ajrhss-623	77	51	(	(	PUNCT
ajrhss-623	77	52	594	594	NUM
ajrhss-623	77	53	)	)	PUNCT
ajrhss-623	77	54	,	,	PUNCT
ajrhss-623	77	55	(	(	PUNCT
ajrhss-623	77	56	2022	2022	NUM
ajrhss-623	77	57	)	)	PUNCT
ajrhss-623	77	58	.	.	PUNCT
ajrhss-623	78	1	8	8	X
ajrhss-623	78	2	.	.	X
ajrhss-623	79	1	l.m	l.m	PROPN
ajrhss-623	79	2	.	.	PROPN
ajrhss-623	79	3	kappusheva	kappusheva	PROPN
ajrhss-623	79	4	,	,	PUNCT
ajrhss-623	79	5	l.m	l.m	PROPN
ajrhss-623	79	6	.	.	PROPN
ajrhss-623	79	7	mikhaleva	mikhaleva	PROPN
ajrhss-623	79	8	,	,	PUNCT
ajrhss-623	79	9	v.g	v.g	PROPN
ajrhss-623	79	10	.	.	PROPN
ajrhss-623	79	11	breusenko	breusenko	PROPN
ajrhss-623	79	12	,	,	PUNCT
ajrhss-623	79	13	g.n	g.n	PROPN
ajrhss-623	79	14	.	.	PROPN
ajrhss-623	79	15	golukhov	golukhov	PROPN
ajrhss-623	79	16	,	,	PUNCT
ajrhss-623	79	17	k.yu	k.yu	PROPN
ajrhss-623	79	18	.	.	PROPN
ajrhss-623	79	19	midiber	midiber	PROPN
ajrhss-623	79	20	,	,	PUNCT
ajrhss-623	79	21	a.e	a.e	PROPN
ajrhss-623	79	22	.	.	PROPN
ajrhss-623	79	23	biryukov	biryukov	PROPN
ajrhss-623	79	24	,	,	PUNCT
ajrhss-623	79	25	a.v	a.v	PROPN
ajrhss-623	79	26	.	.	PROPN
ajrhss-623	79	27	ovchinnikova	ovchinnikova	PROPN
ajrhss-623	79	28	,	,	PUNCT
ajrhss-623	79	29	d.s	d.s	PROPN
ajrhss-623	79	30	.	.	PROPN
ajrhss-623	79	31	gutorova	gutorova	PROPN
ajrhss-623	79	32	,	,	PUNCT
ajrhss-623	79	33	k.v	k.v	PROPN
ajrhss-623	79	34	.	.	PROPN
ajrhss-623	79	35	scherbatyuk	scherbatyuk	PROPN
ajrhss-623	79	36	,	,	PUNCT
ajrhss-623	79	37	hormonal	hormonal	ADJ
ajrhss-623	79	38	therapy	therapy	NOUN
ajrhss-623	79	39	in	in	ADP
ajrhss-623	79	40	patients	patient	NOUN
ajrhss-623	79	41	of	of	ADP
ajrhss-623	79	42	reproductive	reproductive	ADJ
ajrhss-623	79	43	age	age	NOUN
ajrhss-623	79	44	with	with	ADP
ajrhss-623	79	45	endometrial	endometrial	ADJ
ajrhss-623	79	46	hyperplasia	hyperplasia	NOUN
ajrhss-623	79	47	without	without	ADP
ajrhss-623	79	48	atypia	atypia	PROPN
ajrhss-623	79	49	.	.	PUNCT
ajrhss-623	80	1	immunohistochemical	immunohistochemical	ADJ
ajrhss-623	80	2	predictors	predictor	NOUN
ajrhss-623	80	3	of	of	ADP
ajrhss-623	80	4	efficacy	efficacy	NOUN
ajrhss-623	80	5	,	,	PUNCT
ajrhss-623	80	6	rossiiskii	rossiiskii	ADJ
ajrhss-623	80	7	vestnik	vestnik	X
ajrhss-623	80	8	akushera	akushera	PROPN
ajrhss-623	80	9	-	-	PUNCT
ajrhss-623	80	10	ginekologa	ginekologa	PROPN
ajrhss-623	80	11	,	,	PUNCT
ajrhss-623	80	12	10.17116	10.17116	NUM
ajrhss-623	80	13	/	/	SYM
ajrhss-623	80	14	rosakush20222205122	rosakush20222205122	PROPN
ajrhss-623	80	15	,	,	PUNCT
ajrhss-623	80	16	22	22	NUM
ajrhss-623	80	17	,	,	PUNCT
ajrhss-623	80	18	5	5	NUM
ajrhss-623	80	19	,	,	PUNCT
ajrhss-623	80	20	(	(	PUNCT
ajrhss-623	80	21	22	22	NUM
ajrhss-623	80	22	)	)	PUNCT
ajrhss-623	80	23	,	,	PUNCT
ajrhss-623	80	24	(	(	PUNCT
ajrhss-623	80	25	2022	2022	NUM
ajrhss-623	80	26	)	)	PUNCT
ajrhss-623	80	27	.	.	PUNCT
ajrhss-623	81	1	9.k	9.k	NUM
ajrhss-623	81	2	renuka	renuka	NOUN
ajrhss-623	81	3	,	,	PUNCT
ajrhss-623	81	4	lavanya	lavanya	ADJ
ajrhss-623	81	5	sankar	sankar	NOUN
ajrhss-623	81	6	,	,	PUNCT
ajrhss-623	81	7	r	r	NOUN
ajrhss-623	81	8	iniyaval	iniyaval	NOUN
ajrhss-623	81	9	,	,	PUNCT
ajrhss-623	81	10	b	b	PROPN
ajrhss-623	81	11	jayanthi	jayanthi	PROPN
ajrhss-623	81	12	,	,	PUNCT
ajrhss-623	81	13	a	a	DET
ajrhss-623	81	14	study	study	NOUN
ajrhss-623	81	15	to	to	PART
ajrhss-623	81	16	assess	assess	VERB
ajrhss-623	81	17	the	the	DET
ajrhss-623	81	18	prevalence	prevalence	NOUN
ajrhss-623	81	19	and	and	CCONJ
ajrhss-623	81	20	contributing	contribute	VERB
ajrhss-623	81	21	factors	factor	NOUN
ajrhss-623	81	22	of	of	ADP
ajrhss-623	81	23	abnormal	abnormal	ADJ
ajrhss-623	81	24	uterine	uterine	ADJ
ajrhss-623	81	25	bleeding	bleed	VERB
ajrhss-623	81	26	among	among	ADP
ajrhss-623	81	27	women	woman	NOUN
ajrhss-623	81	28	admitted	admit	VERB
ajrhss-623	81	29	in	in	ADP
ajrhss-623	81	30	mgmcri	mgmcri	NOUN
ajrhss-623	81	31	from	from	ADP
ajrhss-623	81	32	january	january	PROPN
ajrhss-623	81	33	to	to	ADP
ajrhss-623	81	34	december	december	PROPN
ajrhss-623	81	35	2019	2019	NUM
ajrhss-623	81	36	,	,	PUNCT
ajrhss-623	81	37	pondicherry	pondicherry	PROPN
ajrhss-623	81	38	journal	journal	NOUN
ajrhss-623	81	39	of	of	ADP
ajrhss-623	81	40	nursing	nursing	NOUN
ajrhss-623	81	41	,	,	PUNCT
ajrhss-623	81	42	10.5005	10.5005	NUM
ajrhss-623	81	43	/	/	SYM
ajrhss-623	81	44	jp	jp	NOUN
ajrhss-623	81	45	-	-	PUNCT
ajrhss-623	81	46	journals-10084	journals-10084	NOUN
ajrhss-623	81	47	-	-	PUNCT
ajrhss-623	81	48	12173	12173	NUM
ajrhss-623	81	49	,	,	PUNCT
ajrhss-623	81	50	14	14	NUM
ajrhss-623	81	51	,	,	PUNCT
ajrhss-623	81	52	1	1	NUM
ajrhss-623	81	53	,	,	PUNCT
ajrhss-623	81	54	(	(	PUNCT
ajrhss-623	81	55	8	8	NUM
ajrhss-623	81	56	-	-	SYM
ajrhss-623	81	57	10	10	NUM
ajrhss-623	81	58	)	)	PUNCT
ajrhss-623	81	59	,	,	PUNCT
ajrhss-623	81	60	(	(	PUNCT
ajrhss-623	81	61	2021	2021	NUM
ajrhss-623	81	62	)	)	PUNCT
ajrhss-623	81	63	.	.	PUNCT
ajrhss-623	82	1	american	american	PROPN
ajrhss-623	82	2	journal	journal	PROPN
ajrhss-623	82	3	of	of	ADP
ajrhss-623	82	4	research	research	NOUN
ajrhss-623	82	5	in	in	ADP
ajrhss-623	82	6	humanities	humanity	NOUN
ajrhss-623	82	7	and	and	CCONJ
ajrhss-623	82	8	social	social	ADJ
ajrhss-623	82	9	sciences	science	NOUN
ajrhss-623	82	10	volume	volume	NOUN
ajrhss-623	82	11	11	11	NUM
ajrhss-623	82	12	,	,	PUNCT
ajrhss-623	82	13	april	april	PROPN
ajrhss-623	82	14	,	,	PUNCT
ajrhss-623	82	15	2023	2023	NUM
ajrhss-623	82	16	p	p	NOUN
ajrhss-623	82	17	a	a	DET
ajrhss-623	82	18	g	g	NOUN
ajrhss-623	82	19	e	e	NOUN
ajrhss-623	83	1	|	|	ADV
ajrhss-623	83	2	70	70	NUM
ajrhss-623	83	3	www.americanjournal.org	www.americanjournal.org	PROPN
ajrhss-623	83	4	10.shan	10.shan	NUM
ajrhss-623	83	5	deng	deng	PROPN
ajrhss-623	83	6	,	,	PUNCT
ajrhss-623	83	7	jinhua	jinhua	PROPN
ajrhss-623	83	8	leng	leng	PROPN
ajrhss-623	83	9	,	,	PUNCT
ajrhss-623	83	10	adenomyosis	adenomyosis	NOUN
ajrhss-623	83	11	and	and	CCONJ
ajrhss-623	83	12	abnormal	abnormal	ADJ
ajrhss-623	83	13	uterine	uterine	ADJ
ajrhss-623	83	14	bleeding	bleeding	NOUN
ajrhss-623	83	15	,	,	PUNCT
ajrhss-623	83	16	adenomyosis	adenomyosis	NOUN
ajrhss-623	83	17	,	,	PUNCT
ajrhss-623	83	18	10.1007/978	10.1007/978	PROPN
ajrhss-623	83	19	-	-	SYM
ajrhss-623	83	20	981	981	NUM
ajrhss-623	83	21	-	-	PUNCT
ajrhss-623	83	22	33	33	NUM
ajrhss-623	83	23	-	-	PUNCT
ajrhss-623	83	24	4095	4095	NUM
ajrhss-623	83	25	-	-	SYM
ajrhss-623	83	26	4_6	4_6	NUM
ajrhss-623	83	27	,	,	PUNCT
ajrhss-623	83	28	(	(	PUNCT
ajrhss-623	83	29	47	47	NUM
ajrhss-623	83	30	-	-	SYM
ajrhss-623	83	31	52	52	NUM
ajrhss-623	83	32	)	)	PUNCT
ajrhss-623	83	33	,	,	PUNCT
ajrhss-623	83	34	(	(	PUNCT
ajrhss-623	83	35	2021	2021	NUM
ajrhss-623	83	36	)	)	PUNCT
ajrhss-623	83	37	.	.	PUNCT
ajrhss-623	84	1	carlo	carlo	PROPN
ajrhss-623	84	2	bastianelli	bastianelli	PROPN
ajrhss-623	84	3	,	,	PUNCT
ajrhss-623	84	4	manuela	manuela	PROPN
ajrhss-623	84	5	farris	farris	PROPN
ajrhss-623	84	6	,	,	PUNCT
ajrhss-623	84	7	vincenzina	vincenzina	PROPN
ajrhss-623	84	8	bruni	bruni	PROPN
ajrhss-623	84	9	,	,	PUNCT
ajrhss-623	84	10	elena	elena	PROPN
ajrhss-623	84	11	rosato	rosato	PROPN
ajrhss-623	84	12	,	,	PUNCT
ajrhss-623	84	13	ivo	ivo	PROPN
ajrhss-623	84	14	brosens	brosens	PROPN
ajrhss-623	84	15	,	,	PUNCT
ajrhss-623	84	16	giuseppe	giuseppe	PROPN
ajrhss-623	84	17	benagiano	benagiano	PROPN
ajrhss-623	84	18	,	,	PUNCT
ajrhss-623	84	19	effects	effect	NOUN
ajrhss-623	84	20	of	of	ADP
ajrhss-623	84	21	progestin	progestin	NOUN
ajrhss-623	84	22	-	-	PUNCT
ajrhss-623	84	23	only	only	ADV
ajrhss-623	84	24	contraceptives	contraceptive	NOUN
ajrhss-623	84	25	on	on	ADP
ajrhss-623	84	26	the	the	DET
ajrhss-623	84	27	endometrium	endometrium	NOUN
ajrhss-623	84	28	,	,	PUNCT
ajrhss-623	84	29	expert	expert	NOUN
ajrhss-623	84	30	review	review	NOUN
ajrhss-623	84	31	of	of	ADP
ajrhss-623	84	32	clinical	clinical	ADJ
ajrhss-623	84	33	pharmacology	pharmacology	NOUN
ajrhss-623	84	34	,	,	PUNCT
ajrhss-623	84	35	10.1080/17512433.2020.1821649	10.1080/17512433.2020.1821649	NUM
ajrhss-623	84	36	,	,	PUNCT
ajrhss-623	84	37	13	13	NUM
ajrhss-623	84	38	,	,	PUNCT
ajrhss-623	84	39	10	10	NUM
ajrhss-623	84	40	,	,	PUNCT
ajrhss-623	84	41	(	(	PUNCT
ajrhss-623	84	42	1103	1103	NUM
ajrhss-623	84	43	-	-	SYM
ajrhss-623	84	44	1123	1123	NUM
ajrhss-623	84	45	)	)	PUNCT
ajrhss-623	84	46	,	,	PUNCT
ajrhss-623	84	47	(	(	PUNCT
ajrhss-623	84	48	2020	2020	NUM
ajrhss-623	84	49	)	)	PUNCT
ajrhss-623	84	50	.	.	PUNCT
ajrhss-623	85	1	11	11	NUM
ajrhss-623	85	2	.	.	PUNCT
ajrhss-623	86	1	juana	juana	PROPN
ajrhss-623	86	2	serret	serret	PROPN
ajrhss-623	86	3	-	-	PUNCT
ajrhss-623	86	4	montaya	montaya	NOUN
ajrhss-623	86	5	,	,	PUNCT
ajrhss-623	86	6	jessie	jessie	PROPN
ajrhss-623	86	7	n.	n.	PROPN
ajrhss-623	86	8	zurita	zurita	PROPN
ajrhss-623	86	9	-	-	PUNCT
ajrhss-623	86	10	cruz	cruz	PROPN
ajrhss-623	86	11	,	,	PUNCT
ajrhss-623	86	12	miguel	miguel	PROPN
ajrhss-623	86	13	a.	a.	PROPN
ajrhss-623	86	14	villasís	villasís	PROPN
ajrhss-623	86	15	-	-	PUNCT
ajrhss-623	86	16	keever	keever	PROPN
ajrhss-623	86	17	,	,	PUNCT
ajrhss-623	86	18	alejandra	alejandra	PROPN
ajrhss-623	86	19	aguilarkitsu	aguilarkitsu	PROPN
ajrhss-623	86	20	,	,	PUNCT
ajrhss-623	86	21	claudia	claudia	PROPN
ajrhss-623	86	22	del	del	PROPN
ajrhss-623	86	23	carmen	carmen	PROPN
ajrhss-623	86	24	zepeda	zepeda	PROPN
ajrhss-623	86	25	-	-	PUNCT
ajrhss-623	86	26	martinez	martinez	PROPN
ajrhss-623	86	27	,	,	PUNCT
ajrhss-623	86	28	irving	irving	PROPN
ajrhss-623	86	29	cruz	cruz	PROPN
ajrhss-623	86	30	-	-	PUNCT
ajrhss-623	86	31	anleu	anleu	NOUN
ajrhss-623	86	32	,	,	PUNCT
ajrhss-623	86	33	beatriz	beatriz	PROPN
ajrhss-623	86	34	c.	c.	PROPN
ajrhss-623	86	35	hernándezhernández	hernándezhernández	PROPN
ajrhss-623	86	36	,	,	PUNCT
ajrhss-623	86	37	sara	sara	PROPN
ajrhss-623	86	38	r.	r.	PROPN
ajrhss-623	86	39	alonso	alonso	PROPN
ajrhss-623	86	40	-	-	PUNCT
ajrhss-623	86	41	flores	flore	NOUN
ajrhss-623	86	42	,	,	PUNCT
ajrhss-623	86	43	leticia	leticia	PROPN
ajrhss-623	86	44	manuel	manuel	NOUN
ajrhss-623	86	45	-	-	PUNCT
ajrhss-623	86	46	apolinar	apolinar	NOUN
ajrhss-623	86	47	,	,	PUNCT
ajrhss-623	86	48	leticia	leticia	PROPN
ajrhss-623	86	49	damasio	damasio	PROPN
ajrhss-623	86	50	-	-	PUNCT
ajrhss-623	86	51	santana	santana	PROPN
ajrhss-623	86	52	,	,	PUNCT
ajrhss-623	86	53	abigail	abigail	PROPN
ajrhss-623	86	54	hernandez	hernandez	PROPN
ajrhss-623	86	55	-	-	PUNCT
ajrhss-623	86	56	cabezza	cabezza	PROPN
ajrhss-623	86	57	,	,	PUNCT
ajrhss-623	86	58	josé	josé	PROPN
ajrhss-623	86	59	c.	c.	PROPN
ajrhss-623	86	60	romo	romo	PROPN
ajrhss-623	86	61	-	-	PUNCT
ajrhss-623	86	62	vázquez	vázquez	NOUN
ajrhss-623	86	63	,	,	PUNCT
ajrhss-623	86	64	hyperprolactinemia	hyperprolactinemia	INTJ
ajrhss-623	86	65	as	as	ADP
ajrhss-623	86	66	a	a	DET
ajrhss-623	86	67	prognostic	prognostic	ADJ
ajrhss-623	86	68	factor	factor	NOUN
ajrhss-623	86	69	for	for	ADP
ajrhss-623	86	70	menstrual	menstrual	ADJ
ajrhss-623	86	71	disorders	disorder	NOUN
ajrhss-623	86	72	in	in	ADP
ajrhss-623	86	73	female	female	ADJ
ajrhss-623	86	74	adolescents	adolescent	NOUN
ajrhss-623	86	75	with	with	ADP
ajrhss-623	86	76	advanced	advanced	ADJ
ajrhss-623	86	77	chronic	chronic	ADJ
ajrhss-623	86	78	kidney	kidney	NOUN
ajrhss-623	86	79	disease	disease	NOUN
ajrhss-623	86	80	,	,	PUNCT
ajrhss-623	86	81	pediatric	pediatric	ADJ
ajrhss-623	86	82	nephrology	nephrology	NOUN
ajrhss-623	86	83	,	,	PUNCT
ajrhss-623	86	84	10.1007	10.1007	NUM
ajrhss-623	86	85	/	/	SYM
ajrhss-623	86	86	s00467	s00467	NOUN
ajrhss-623	86	87	-	-	PUNCT
ajrhss-623	86	88	020	020	NUM
ajrhss-623	86	89	-	-	PUNCT
ajrhss-623	86	90	04494	04494	NUM
ajrhss-623	86	91	-	-	PUNCT
ajrhss-623	86	92	7	7	NUM
ajrhss-623	86	93	,	,	PUNCT
ajrhss-623	86	94	(	(	PUNCT
ajrhss-623	86	95	2020	2020	NUM
ajrhss-623	86	96	)	)	PUNCT
ajrhss-623	86	97	.	.	PUNCT
ajrhss-623	87	1	12.myriam	12.myriam	NUM
ajrhss-623	87	2	kossaï	kossaï	ADJ
ajrhss-623	87	3	,	,	PUNCT
ajrhss-623	87	4	frédérique	frédérique	ADJ
ajrhss-623	87	5	penault	penault	NOUN
ajrhss-623	87	6	-	-	PUNCT
ajrhss-623	87	7	llorca	llorca	NOUN
ajrhss-623	87	8	,	,	PUNCT
ajrhss-623	87	9	role	role	NOUN
ajrhss-623	87	10	of	of	ADP
ajrhss-623	87	11	hormones	hormone	NOUN
ajrhss-623	87	12	in	in	ADP
ajrhss-623	87	13	common	common	ADJ
ajrhss-623	87	14	benign	benign	ADJ
ajrhss-623	87	15	uterine	uterine	ADJ
ajrhss-623	87	16	lesions	lesion	NOUN
ajrhss-623	87	17	:	:	PUNCT
ajrhss-623	87	18	endometrial	endometrial	ADJ
ajrhss-623	87	19	polyps	polyp	NOUN
ajrhss-623	87	20	,	,	PUNCT
ajrhss-623	87	21	leiomyomas	leiomyoma	NOUN
ajrhss-623	87	22	,	,	PUNCT
ajrhss-623	87	23	and	and	CCONJ
ajrhss-623	87	24	adenomyosis	adenomyosis	NOUN
ajrhss-623	87	25	,	,	PUNCT
ajrhss-623	87	26	hormonal	hormonal	ADJ
ajrhss-623	87	27	pathology	pathology	NOUN
ajrhss-623	87	28	of	of	ADP
ajrhss-623	87	29	the	the	DET
ajrhss-623	87	30	uterus	uterus	NOUN
ajrhss-623	87	31	,	,	PUNCT
ajrhss-623	87	32	10.1007/978	10.1007/978	NUM
ajrhss-623	87	33	-	-	SYM
ajrhss-623	87	34	3	3	NUM
ajrhss-623	87	35	-	-	PUNCT
ajrhss-623	87	36	030	030	NUM
ajrhss-623	87	37	-	-	PUNCT
ajrhss-623	87	38	38474	38474	NUM
ajrhss-623	87	39	-	-	PUNCT
ajrhss-623	87	40	6_3	6_3	NUM
ajrhss-623	87	41	,	,	PUNCT
ajrhss-623	87	42	(	(	PUNCT
ajrhss-623	87	43	37	37	NUM
ajrhss-623	87	44	-	-	SYM
ajrhss-623	87	45	58	58	NUM
ajrhss-623	87	46	)	)	PUNCT
ajrhss-623	87	47	,	,	PUNCT
ajrhss-623	87	48	(	(	PUNCT
ajrhss-623	87	49	2020	2020	NUM
ajrhss-623	87	50	)	)	PUNCT
ajrhss-623	87	51	.	.	PUNCT
ajrhss-623	88	1	13.rahel	13.rahel	NUM
ajrhss-623	88	2	a.	a.	PROPN
ajrhss-623	88	3	kubik	kubik	PROPN
ajrhss-623	88	4	-	-	PUNCT
ajrhss-623	88	5	huch	huch	PROPN
ajrhss-623	88	6	,	,	PUNCT
ajrhss-623	88	7	michael	michael	PROPN
ajrhss-623	88	8	weston	weston	PROPN
ajrhss-623	88	9	,	,	PUNCT
ajrhss-623	88	10	stephanie	stephanie	PROPN
ajrhss-623	88	11	nougaret	nougaret	PROPN
ajrhss-623	88	12	,	,	PUNCT
ajrhss-623	88	13	henrik	henrik	PROPN
ajrhss-623	88	14	leonhardt	leonhardt	PROPN
ajrhss-623	88	15	,	,	PUNCT
ajrhss-623	88	16	isabelle	isabelle	PROPN
ajrhss-623	88	17	thomassin	thomassin	PROPN
ajrhss-623	88	18	-	-	PUNCT
ajrhss-623	88	19	naggara	naggara	PROPN
ajrhss-623	88	20	,	,	PUNCT
ajrhss-623	88	21	mariana	mariana	PROPN
ajrhss-623	88	22	horta	horta	PROPN
ajrhss-623	88	23	,	,	PUNCT
ajrhss-623	88	24	teresa	teresa	PROPN
ajrhss-623	88	25	margarida	margarida	PROPN
ajrhss-623	88	26	cunha	cunha	PROPN
ajrhss-623	88	27	,	,	PUNCT
ajrhss-623	88	28	cristina	cristina	PROPN
ajrhss-623	88	29	maciel	maciel	PROPN
ajrhss-623	88	30	,	,	PUNCT
ajrhss-623	88	31	andrea	andrea	PROPN
ajrhss-623	88	32	rockall	rockall	PROPN
ajrhss-623	88	33	,	,	PUNCT
ajrhss-623	88	34	rosemarie	rosemarie	PROPN
ajrhss-623	88	35	forstner	forstner	PROPN
ajrhss-623	88	36	,	,	PUNCT
ajrhss-623	88	37	european	european	ADJ
ajrhss-623	88	38	society	society	NOUN
ajrhss-623	88	39	of	of	ADP
ajrhss-623	88	40	urogenital	urogenital	ADJ
ajrhss-623	88	41	radiology	radiology	NOUN
ajrhss-623	88	42	(	(	PUNCT
ajrhss-623	88	43	esur	esur	PROPN
ajrhss-623	88	44	)	)	PUNCT
ajrhss-623	88	45	guidelines	guideline	NOUN
ajrhss-623	88	46	:	:	PUNCT
ajrhss-623	88	47	mr	mr	PROPN
ajrhss-623	88	48	imaging	imaging	NOUN
ajrhss-623	88	49	of	of	ADP
ajrhss-623	88	50	leiomyomas	leiomyomas	PROPN
ajrhss-623	88	51	,	,	PUNCT
ajrhss-623	88	52	european	european	ADJ
ajrhss-623	88	53	radiology	radiology	NOUN
ajrhss-623	88	54	,	,	PUNCT
ajrhss-623	88	55	10.1007	10.1007	NUM
ajrhss-623	88	56	/	/	SYM
ajrhss-623	88	57	s00330	s00330	NOUN
ajrhss-623	88	58	-	-	PUNCT
ajrhss-623	88	59	017	017	NUM
ajrhss-623	88	60	-	-	PUNCT
ajrhss-623	88	61	5157	5157	NUM
ajrhss-623	88	62	-	-	SYM
ajrhss-623	88	63	5	5	NUM
ajrhss-623	88	64	,	,	PUNCT
ajrhss-623	88	65	28	28	NUM
ajrhss-623	88	66	,	,	PUNCT
ajrhss-623	88	67	8	8	NUM
ajrhss-623	88	68	,	,	PUNCT
ajrhss-623	88	69	(	(	PUNCT
ajrhss-623	88	70	3125	3125	NUM
ajrhss-623	88	71	-	-	SYM
ajrhss-623	88	72	3137	3137	NUM
ajrhss-623	88	73	)	)	PUNCT
ajrhss-623	88	74	,	,	PUNCT
ajrhss-623	88	75	(	(	PUNCT
ajrhss-623	88	76	2018	2018	NUM
ajrhss-623	88	77	)	)	PUNCT
ajrhss-623	88	78	.	.	PUNCT
ajrhss-623	89	1	14.frances	14.frances	NUM
ajrhss-623	89	2	e.	e.	PROPN
ajrhss-623	89	3	likis	likis	PROPN
ajrhss-623	89	4	,	,	PUNCT
ajrhss-623	89	5	women	woman	NOUN
ajrhss-623	89	6	's	's	PART
ajrhss-623	89	7	health	health	NOUN
ajrhss-623	89	8	across	across	ADP
ajrhss-623	89	9	the	the	DET
ajrhss-623	89	10	lifespan	lifespan	NOUN
ajrhss-623	89	11	:	:	PUNCT
ajrhss-623	89	12	a	a	DET
ajrhss-623	89	13	continuing	continue	VERB
ajrhss-623	89	14	education	education	NOUN
ajrhss-623	89	15	theme	theme	NOUN
ajrhss-623	89	16	issue	issue	NOUN
ajrhss-623	89	17	,	,	PUNCT
ajrhss-623	89	18	journal	journal	NOUN
ajrhss-623	89	19	of	of	ADP
ajrhss-623	89	20	midwifery	midwifery	NOUN
ajrhss-623	89	21	&	&	CCONJ
ajrhss-623	89	22	women	woman	NOUN
ajrhss-623	89	23	's	's	PART
ajrhss-623	89	24	health	health	NOUN
ajrhss-623	89	25	,	,	PUNCT
ajrhss-623	89	26	10.1111	10.1111	NUM
ajrhss-623	89	27	/	/	SYM
ajrhss-623	89	28	jmwh.12495	jmwh.12495	PROPN
ajrhss-623	89	29	,	,	PUNCT
ajrhss-623	89	30	61	61	NUM
ajrhss-623	89	31	,	,	PUNCT
ajrhss-623	89	32	3	3	NUM
ajrhss-623	89	33	,	,	PUNCT
ajrhss-623	89	34	(	(	PUNCT
ajrhss-623	89	35	304	304	NUM
ajrhss-623	89	36	-	-	SYM
ajrhss-623	89	37	305	305	NUM
ajrhss-623	89	38	)	)	PUNCT
ajrhss-623	89	39	,	,	PUNCT
ajrhss-623	89	40	(	(	PUNCT
ajrhss-623	89	41	2016	2016	NUM
ajrhss-623	89	42	)	)	PUNCT
ajrhss-623	89	43	.	.	PUNCT